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ABSTRACT 
Petroleum is one of the most important natural resources, but can also be problematic to 
environmental and human health. Petroleum is comprised of thousands of compounds, 
including polycyclic aromatic hydrocarbons (P AHs) and heterocycles, some of which are 
toxic and/or carcinogenic. Traditional analytical methods for environmental monitoring 
oflow-level PAHs are time-consuming, labor-intensive, and often laboratory-bound. 
Efforts to achieve timely, sensitive, and accurate analysis of PAHs in the field have 
become a priority for environmental research and monitoring. Antibody-based 
biosensors are presently being developed for environmental analysis. Anti-PAH antibody 
molecules can be coupled with electronic transducers to provide new biosensor 
technology for the rapid determination and quantification of P AHs. Although P AHs are 
not immunogenic on their own, advances in immunology have provided the means to 
develop antibodies to P AHs. 
Thiophenes, a defined subset of aromatic heterocycles, were selected as the target 
molecules for antibody development. Characterization of a monoclonal antibody (mAb) 
to dibenzothiophene revealed specificity for 3 to 5-ring PAHs and heterocycles. 
Therefore, the goals of antibody development were focused on developing additional 
antibodies to 2-ring P AHs and to alkylated P AHs. Characterization of antibodies to these 
novel targets revealed unexpected insights into antibody induction and specificity; 
namely suitable hapten sizes for small hydrophobic molecule recognition should be larger 
than one benzene ring, derivatization of the hapten target in immunogen synthesis must 
preserve structural characteristics, the utility of heterologous assay formats can improve 
antibody inhibition, and high antibody titers can result in limited assay sensitivity. 
The anti-dibenzothiophene mAb 7B2.3 was employed, along with a fluorescence-based 
transducer, for the generation of a new biosensor for P AHs. The biosensor was utilized 
in a variety of different applications to determine dissolved PAH concentrations 
including: 1) sampling groundwater at a former wood-treatment (creosote) facility, 2) 
analyzing estuarine water during the dredging of PAR-contaminated sediments, revealing 
a plume of P AHs emanating from the dredge site, 3) frequent monitoring of phenanthrene 
(a 3-ring PAH) concentrations during a laboratory toxicological dosing study, and 4) 
monitoring P AH concentrations in storm water runoff into both a retention pond and a 
river near a roadway. 
Overall, these applications demonstrated the utility of this biosensor for rapid analysis of 
P AHs in a variety of aqueous environments. The biosensor was operated on-site for both 
the estuarine and groundwater monitoring trials. The biosensor could process samples, 
produce quantitative measurements, and regenerate itself in approximately 10 minutes. 
Sample volumes of 400 J.Ll could be used with little to no sample pretreatment. Most 
importantly, PAHs could be quantified down to 0.3 J.Lg/1 in the field using the sensor 
platform. These results were validated with conventional gas chromatography-mass 
spectrometry and high performance liquid chromatography analytical methods. This 
system shows great promise as a field instrument for the rapid monitoring of P AH 
pollution. 
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The Development and Application of an Antibody-based Biosensor 
for the Detection of Petroleum-derived Compounds 
INTRODUCTION 
Petroleum 
Petroleum as a pollutant 
Petroleum is one of the most important natural resources. It is extensively used for fuel, 
plastics, fertilizers, and artificial fibers in clothing, in addition to other common products. 
However, it becomes problematic when it enters the environment resulting in deleterious 
effects on ecosystem and human health. Although some of the petroleum that enters the 
aquatic environment is from natural seepages, the more detrimental inputs are from 
extraction, transportation, and consumption of petroleum (NRC 2003). These petroleum 
inputs include, but are not limited to, land-based runoff, recreational vessel discharge, 
operational discharges, spills, pipeline leaks, atmospheric deposition, and aircraft 
dumping (NRC 2003). The potential for accidental release into the aquatic environment 
is magnified in areas where transportation, storage, or use is centered near waterways. If 
and when spills occur, there is a need for immediate and sensitive water quality 
assessments to better understand the potential harm to sensitive aquatic habitats. 
Petroleum composition, characteristics, andfate 
Petroleum is formed from the ancient remains of marine plant and animal life under 
extreme heat and pressure in an anaerobic environment. Depending on the composition 
of the organic material, varying proportions of aliphatic or aromatic hydrocarbons will be 
formed. The third most abundant element in petroleum is sulfur, which can account for 
0.05 to 13.9% of the total weight depending upon the source of the petroleum (Kropp and 
Fedorak 1998). 
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The polycyclic aromatic hydrocarbons (PAHs) can be divided into two groups based on 
their physical and chemical characteristics. For my purposes, the low molecular weight 
P AHs include the 2- to 3-ring structures while the high molecular weight P AHs are those 
with 4- to 5-rings (Figure 1). Generally speaking, as the molecular weight increases, 
PAH aqueous solubility decreases, as does their susceptibility to vaporization (Neff 
1979). Furthermore, alkyl substitutions on the aromatic ring results in an overall 
decrease in PAH solubility. Solubility is enhanced three- to four-fold by a rise in 
temperatures from 5 to 30°C, and by dissolved and colloidal organic fractions which 
incorporate PAHs into micelles (Neff 1979). Vapor pressure characteristics influence the 
persistence of P AHs in the aquatic environment, with low molecular weight P AHs being 
more volatile and high molecular weight P AHs demonstrating insignificant 
volatilizationalloss under all environmental conditions (Moore and Ramamoorthy 1984 ). 
As a result of these varying characteristics, P AHs will differ in their behavior, 
distribution, and biological effects. 
Although PAHs are hydrophobic, they are slightly soluble in water, and those that are 
soluble in water are therefore termed the water-accommodated fraction (WAF). In fact, 
the aquatic ecosystem is one of the major sinks ofPAH contamination (Tao et al. 2003). 
Due to their hydrophobic nature, P AHs entering the aquatic environment exhibit a high 
affinity for suspended particulates in the water column and will tend to sorb to these 
particles (Kayal and Connell 1990, Shi et al. 2007). Because of this partitioning with the 
sediments, the PAH concentrations in water are usually quite low relative to bottom 
sediments (Moore and Ramamoorthy 1984). Moreover, because of their hydrophobic 
nature and high lipophilicity PAHs are known to bioaccumulate in aquatic organisms 
(Meador et al. 1995). The overall fate of a PAH fraction will highly depend on the 
temperature, turbulence, depth, and pollution status of the water (NRC 2003). As a 
result, loss/degradation of a PAH will vary both in time and space. 
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low molecular weight PAHs: 
high molecular weight PAHs: 
~~;~ 
\A.:# 
('"~) "''"'~.,)! 
naphthalene acenaphthalene 
~r~, 
..r-,r-"yl \:~>--01 
fluoranthene pyrene 
~ 
~y\~ ~~J,-¥) 
acenaphthylene 
chrysene 
Figure 1. Structures and names of selected P AHs. 
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CJ;lr""'> 1vv""'~ 
benzo[a]pyrene 
Toxicity from the WAF of petroleum 
Despite the lower concentrations in theW AF, it is this bioavailable fraction that is 
responsible for the aquatic toxicity associated with petroleum (Byrne and Calder 1977, 
Nicolet al. 1977, Millemann et al. 1984, Neff et al. 2000, Mori et al. 2002, Neff et al. 
2005, Rhodes et al. 2005). The low molecular weight PAHs demonstrate significant 
toxicity, whereas the high molecular weight P AHs are less toxic, but are carcinogenic. 
As a general trend, toxicity increases as a PAH gains alkyl groups (Neff et al. 2005). 
Acute toxicity has been seen in a range of species of fish and other aquatic organisms at 
concentrations much less than 1 ppm (mg/1). The alkylated PAHs found in petroleum are 
relatively more abundant, tend to persist longer (i.e., do not volatilize, biodegrade, or 
photooxidize as readily) and bioaccumulate to a greater degree than the non-alkylated 
compounds (Sauer and Uhler 1994). Moreover, Barron and colleagues (1999) postulate 
that perhaps it is not only the PAHs, but also the heterocycles (PAH analogs containing 
sulfur, nitrogen or oxygen) that contribute to the toxicity of theW AF. Similarly, 
heterocycles are expected to follow the same trends as P AHs with regard to increased 
toxicity with increased alkylation and a tendency to bioaccumulate and persist. Within 
the subclass of heterocycles, sulfur-containing analogs, although less studied than PAHs, 
are the next most abundant compounds and are predominantly arylthiophenes 
(benzothiophene, dibenzothiophene, naphthobenzothiophene) and their alkyl derivatives. 
Seymour and coworkers (1997) showed that many of the condensed thiophenes were 
more soluble than the similarly sized P AHs. Research on the fate of thiophenes suggests 
that they persist longer than PAHs in aquatic systems (Kropp and Fedorak 1998). 
Therefore the toxicity, solubility and persistence of polycyclic aromatic heterocycles, 
especially thiophenes, make them excellent targets when monitoring for petroleum 
(Figure 2). 
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benzoth1ophene 5-methylbenzothlophene 3-methylbenzothlophene d1benzoth1ophene 4 6-d1methyldlbenzoth1ophene 
Figure 2. The thiophenes targeted for antibody development. These compounds are 
found in petroleum, in theW AF of petroleum, and demonstrate some acute toxicity. 
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Current technologies for measuring PAHs 
Classical analytical chemistry: laboratory-based methods 
There are several analytical methods available for detecting and measuring PAHs in 
water, sediment, air and biological samples. The earliest and simplest technique is a 
gravimetric analysis in which a sample is extracted using a non-polar organic solvent 
(Stenstrom et al. 1986). The extracted fraction is then evaporated and the residue is 
weighed on a balance. Although this remains a cheap and readily available option for 
quantifying total extracted organics, very large samples must be used for low level 
analysis. In addition, the low molecular weight molecules are commonly lost to 
volatilization and the high molecular weight compounds are often not recovered well in 
liquid/liquid extractions (Stenstrom et al. 1986). Furthermore, there is a high risk of 
extracting naturally-derived compounds, or unrelated compounds, with a similar 
solubility to the P AHs, which makes it inaccurate as a petroleum measuring tool. 
PAHs exhibit high absorptivities of UV radiation. Likewise, they exhibit strong 
fluorescence emission patterns that are specific to aromatic structures (Lee et al. 1981 ). 
Beyond quantification, these techniques allow for differentiation among aromatic 
structures. The disadvantage of these tools is the interference from other similar 
molecules. However, by acquiring proper standards and known material, these 
interferences can be accounted for. The more common and acceptable practice is the 
combination of some form of chromatographic separatory preparation prior to employing 
these technologies for detection. 
Most well-established analytical methods employ gas chromatography (GC, equipped 
with a mass spectrometer (MS) or flame ionization detector) or high-performance liquid 
chromatography (HPLC, coupled with an UV detector or a fluorescence detector) (Poster 
et al. 2006). GC separates complex PAH mixtures via differential partitioning between a 
mobile gas phase and a stationary liquid phase. The polarity-based affinity of the column 
for the compounds permits the differential elution of the P AH compounds whereupon a 
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MS can be employed to speciate the compounds. Employing a similar principle, HPLC 
pumps a mobile liquid phase at high pressure through a column. Compounds are eluted 
from the column and are detected by UV or fluorescence. 
Federal agencies such as the United States Environmental Protection Agency (US EPA) 
and National Institute for Occupational Safety and Health routinely use GC-MS and 
HPLC methods in their protocols for environmental sample analysis (e.g., Methods 8270 
and 8310). A complication to this analysis is that environmental samples involve a 
variety of media (aqueous, solids, sludges, biological samples, or a combination of these). 
Under such conditions, these methods will be compromised by interfering compounds 
having PAH-like physical characteristics, however much of this has been eliminated by 
the use of standards and with the sensitivity of the detection devices (i.e., MS). Thus 
although these methods may be standard for laboratory analyses of environmental 
samples, they suffer considerably as an option for more routine monitoring, as the 
approaches are expensive, labor-intensive, and time-consuming. 
Analytical on-site PAH assessment tools 
Efforts to improve on the laboratory-bound methodologies have become a priority for 
environmental research and monitoring (Rogers 1995, Plaza et al. 2000, Rodriguez-
Mozaz et al. 2006). The goal of developing new on-site assessment technologies is to 
reduce the expertise, time, and equipment needed, as well as offering comparable or 
improved measurements. Other requirements for on-site technologies are to minimize the 
power requirements and to reduce dangerous waste materials (toxic reagents, halogenated 
solvents, etc.), produced. Although not all of these characteristics can be obtained with a 
single tool, the goal is to maximize performance with a minimized input. 
For the analysis of PAHs in motor oil in soil, a thin-layer chromatography (TLC) field 
method has been developed as a screening tool (Newborn and Preston 1991). Following 
separation by TLC, iodine staining and UV exposure were employed for visualization of 
UV active material. Although it only has a detection limit of 100 ppm (ppb detection 
8 
often required), it is a cost-effective tool for preliminary assessments compared to 
bringing every sample back to the laboratory for conventional analysis. 
The first field portable GC-MS has demonstrated environmental analysis capabilities. 
The Viking SpectraTrak™ 672 GC-MS has been verified by the Environmental 
Technology Verification Program created by the US EPA and determined to provide 
detection limits of about 5 ppm for volatile and semi-volatile organic contaminants 
(which includes PAH detection) in air samples, and 5 ppb (jlg/1) for soil and liquid 
samples (1997). The system cost and training starts around $150,000, requires a power 
source during field operation, and the columns are more susceptible to breaking because 
they must be wound around a smaller cage than normally required in the lab (US EPA 
1997). On-scene arson crime investigations made use of these portable GC-MS devices 
when testing for petroleum-based accelerants in the case of arson (Pert et al. 2006). 
Though they are not concerned with quantification, the use of GC allows the ability to 
distinguish between the pyrogenic and petrogenic P AHs. 
This ultimately leads to the most recently employed ICx Griffin 400 field portable GC-
MS instrument, equipped with a helium gas tank, by the Army Corps of Engineers 
(Bednar et al. 2009). Solvent extractions of both sediment and water samples collected 
from the dredging of a P AH -contaminated area were conducted in the field. In addition 
to the time it took for sample preparation, sample analysis required 21 minutes. The 
instrument possessed a field method detection limit of 20 ppb (jlg/1); however none of the 
samples assessed in this study were quantifiable in the field, because they were lower 
than the field method detection limit. The laboratory results confirmed this assessment, 
whereby the authors suggest that this field method produced no false positives or 
negatives. Nonetheless, all of these field-based methods still lack speed, ease of use, and 
sensitivity. 
Overview of immunoassays 
Presently, immunoassays are being developed as tools for environmental monitoring. An 
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immunoassay is a chemical test based on the use of antibodies, which exhibit molecular 
specificity and high affinity binding characteristics for a particular target or antigen. 
Immunoassays allow selective recognition even in complex matrices, due to their 
selective antibody/antigen interaction. Other factors rendering immunoassays as 
desirable tools for environmental analysis are their reliability, low cost, speed of analysis, 
ease of use, portability, and sensitivity (Van Emon and Gerlach 1998). Immunoassays 
can be faster and cheaper to manufacture and use than traditional techniques, as shown in 
Table 1 composed by Plaza et al. (2000). 
The sensitivity of immunoanalysis is reliant on the antibody's affinity. As noted by Van 
Emon and Gerlach (1998), immunoassays have a tendency to report higher analyte 
concentrations when compared to GC-MS or HPLC. They further suggest that this is the 
result of the need for fewer procedural steps, resulting in higher analyte recoveries or 
because of antibody cross-reactivity with similarly structured molecules or derivatives. 
The most commonly employed immunochemical assay is the Enzyme-Linked 
ImmunoSorbent Assay (ELISA), which was first described in 1972 by Eva Engvall and 
Peter Perlman. Though the name suggests it uses enzymes, the actual recognition 
molecule is an antibody, while the enzyme portion is coupled to the antibody to elicit a 
colorimetric signal. An ELISA is a technique that allows for the determination of 
antibodies in a sample. In short, the antigen (analyte) specific to the enzyme-linked 
antibody is immobilized onto a surface. This surface is then exposed to the sample 
allowing antibodies to bind to the antigen-coated surface. After the surface is washed, it 
is immersed in a chromogenic substrate solution resulting in an enzyme-catalyzed 
reaction of the substrate producing a colorimetric change in direct proportion to bound 
antibody. The amount of antibody bound to the antigen is determined from the initial rate 
of reaction, which is proportional to the quantity of enzyme captured. 
In this research, for the most part, a 'competitive inhibition ELISA (cELISA)' is 
performed (Figure 3). An antigen specific to the enzyme-linked antibody is immobilized 
on a surface. This surface is then exposed to the sample in combination with the enzyme-
linked antibodies. If an analyte is present in the sample it will compete with the 
10 
Table 1. Comparison of traditional and immunoassay techniques for environmental 
sampling. Taken from Plaza et al. (2000). 
PROPERTIES TRADmONAL TESTING IMMUNOASSA YS 
- TURNAROUI'iTI TL\ffi 1-4 weeks less than 2 houi'S 
-lEST COST $ 65 - $ 250 per test $ 10 - $ 25 per test 
- PORTABILITY laboratory bound in-lab or on-site 
-ACCURACY high high 
- RELIABILITY high high 
-EASE OF USE dificult moderate to simple 
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Antigen coated surface 
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antigen-coated surface 
generating a measurable 
s1gnalll e greater refractive 
shift. reduced light 1ntens1ty. 
reduced current etc ) 
PAH concentration 
Fewer antibodies are free to 
bind to the antigen-coated 
surface thereby generatmg a 
reduced s1gnal 
Figure 3. An illustration of an antibody assay demonstrating competitive inhibition by 
underivatized PARs in a sample. The resulting signal is inversely proportional to the 
P AH concentration. (Antibodies are illustrated as Y -shaped structures.) 
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immobilized antigen, leaving less antibody molecules available to bind the immobilized 
antigen. During chromogenic development, the rate of reaction, which is proportional to 
the quantity of enzyme captured, is inversely proportional to the quantity of soluble 
antigen (e.g., PAR) in the sample. Examples of commercially available immunoassay 
test kits are home pregnancy tests, RIV tests, and a few environmental monitoring kits for 
PARs. Although PAR-specific immunoassays already exist, it is the goal of this project 
to improve upon the sensitivity of such systems and to link the antibodies with 
instrumentation to make them available as a monitoring tool. 
Commercially available immunoassaysfor PAHs 
Commercially available PAR immunoassays are available through SDIX, Abeam, ExBio, 
Novus Biologicals, Santa Cruz Biotechnology and Quantix Systems. Although they are 
not all explicitly for water analysis, some valuable information can be gleaned from their 
use, as well as, how their assay systems are designed. For instance, the Quantix Systems 
assay is a disposable plastic analyte detector that has been used on wildlife exposed to oil 
in seawater (Mazet et al. 1997). The target antigen (PAR) is conjugated to an enzyme, 
while the anti-PAR antibody was immobilized. This allows for a competitive assay, in 
which the underivatized PAR in the extracted sample can compete with the PAR-enzyme 
to bind the immobilized antibody. The unbound PAR-enzymes will be washed away. 
Subsequently, the chromogenic substrate is introduced and the colored product is 
quantified using a hand-held refractometer. As the PAR concentration in the sample 
increases, the color endpoint decreases in intensity. 
SDIX has offered a variety of field-deployable immunoassays. For the PAR 
immunoassay, samples require extraction of the PAR analytes into an aqueous phase 
before analysis. Chuang et al. (2003) compared the SDIX immunoassay with GC-MS 
concluding that the ELISA measurements are highly correlative and thus is a suitable 
broad screening tool for environmental PAR monitoring. Explicitly, the ELISA often 
provided higher estimates than the GC-MS, which the authors expected because of the 
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ability of the antibody to cross-react with a number of other P AHs not included in the 19 
targeted by the GC-MS method. 
In the published literature on PAH immunoassays, typically ELISA kits use one antibody 
to determine the overall P AH concentration. The concentration is reported as a single 
compound, frequently benzo[a]pyrene. More precisely, the result is reported as 
benzo[a]pyrene equivalents. One goal of this study was to develop antibodies to different 
petroleum targets, lower versus higher molecular weight polycyclic aromatic 
heterocycles. The majority, if not all of the current P AH immunoassays possess a fair 
amount of cross-reactivity. For example, Nording and Haglund (2003) evaluated the 
cross-reactivity of a commercially available antibody induced by phenanthrene. Cross-
reactivity with fluorene was 140% while compounds with a sulfur, nitrogen, oxygen, or 
carbonyl group at the nine position of a fluorene molecule showed cross-reactivity values 
of 28, 8, 7, and 6%, respectively (Figure 4). They concluded that replacing carbon-7 with 
other atoms had an influence on the cross-reactivity. 
Overview of biosensors 
A biosensor is simply a hybrid of biological material capable of molecular recognition 
coupled to an electronic transducer. More advanced instrumentation, such as biosensors, 
can enable remote and automated environmental monitoring. A variety of biorecognition 
elements can be used, such as; enzymes, whole cell receptors, DNA, and antibodies. 
These are then linked with a transducer, such as an electrochemical, optical, 
piezoelectrical, or thermal device, which converts the biorecognition event into a 
quantifiable signal (Nakamura and Karube 2003). Fluorophores or enzymes are often 
used to augment or generate detectible signals. The transduced signal is then recorded as 
a digital output, typically onto a computer facilitated by dedicated software (Figure 5). 
For a summary and discussion of P AH biosensors, see Appendix A. 
Ideally, biosensors should operate automatically with a user simply introducing the 
sample and the sensor producing a digital result. The sample may require user 
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Fluorene (140%) 
Figure 4. Structures of tested compounds (black) superimposed on a contour of the 
phenanthrene molecule (grey), showing the general similarities between molecules, with 
cross-reactivity values in the brackets. (Figure from Nording and Haglund (2003) with 
slight modifications). 
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Figure 5. Schematic of a generalized biosensor. The bioreceptor and the transducer are 
linked such that the transducer quantifies the biorecognition event occurring between the 
sample and the bioreceptor. The arrows indicate user interaction, in which a sample may 
require some manipulation prior to introduction to the biosensor. The resulting data are 
then compared to a standard curve to provide an estimate of analyte concentration. 
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manipulation prior to introduction (as shown by an incomplete arrow in Figure 5). The 
biosensor is responsible for detecting the analytes of interest and translating this 
biorecognition event into a digital output. The resulting data are then compared to a 
standard curve to estimate the concentration of analyte in the sample. 
The goal in developing effective biosensors is to make the technology user-friendly, 
portable, sensitive, accurate, reliable, and inexpensive (Van Emon and Gerlach 1998). 
Biosensors can cost less than traditional analytical techniques, require fewer reagents, 
provide faster turnaround times and higher sample throughput. On-site technologies can 
require minimal use of power, less dangerous reagents, and produce less potentially toxic 
waste. Advances in manufactured materials and miniaturization are facilitating 
portability and on-site operation of biosensors (Rodriguez-Mozaz et al. 2006). 
Unfortunately, the development of many environmental biosensors is still in an immature 
stage, such that automation and portability are often not described nor accomplished. 
Portability is often emphasized as an advantage of biosensors, but rarely have the 
analyses been conducted on-site (Rodriguez-Mozaz et al. 2006). Therefore, it was a goal 
of this project to develop a biosensor for P AH quantification and to demonstrate its 
ability for autonomous operation and portability. 
Moreover, most PAH immunoassay studies used natural water samples fortified with a 
single PAH analyte to test their methods, while only a few have used PAR-contaminated 
water (Barcelo et al. 1998, Li et al. 2000, Beloglazova et al. 2008). In these cases, the 
analysis of contaminated water has fallen short by limiting validation to a sub-set of 
unsubstituted PAHs (typically the 16 EPA priority pollutants) or to a single PAH. 
Immunoassay speed is often limited by the time required for antibody/antigen (i.e., 
analyte) equilibrium to occur. Incubation typically requires 30 to 60 minutes; however, 
antibody kinetics are often not considered in order to optimize timing. 
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Development of antibodies to small molecules 
The success of an immunoassay depends heavily on the affinity characteristics of the 
antibody. Antibodies are formed in vivo as an adaptive specific immune response. The 
use of antibodies has been desirable for the development of diagnostics because of their 
ease of extraction and purification. Antibodies are generated in response to non-self 
antigens, such as bacteria, viruses or toxins. There are molecular features among the 
antigens that direct the immune response to produce antibodies, which include size (1 0 to 
100 kDa), foreignness, and chemical composition. Specifically speaking, 
polysaccharides (composed of repeating epitopes) alone and regardless of their size are 
less effective at producing antibodies, whereas proteins (composed of amino acids and 
having defined conformations) exhibit structural complexity and therefore induce 
antibody production by the induction of somatic mutational processes (Benjamin et al. 
1984). Also intriguing are the cellular processes that antibodies undergo in order to 
obtain high affinity (antigen-driven selection and affinity maturation), with regards to 
specificity and selectivity (Kindt et al. 2007). 
Antibody recognition characteristics 
Strictly speaking antigens are comprised of those molecules and cells that are capable of 
reacting with antibodies, while immunogens comprise a subset of these molecules which 
are capable of inducing antibody formation. (Any substances capable of producing an 
immune response are said to be immunogenic and are called immunogens.) Antigens are 
referred to as the substances an antibody recognizes, and yet, it is not the whole molecule 
that antibodies recognize, but only the small portion that can fit within an antibody 
binding site called the epitope, or antigenic determinant (Pressman and Grossberg 1968). 
In the 1930's, Nobel Prize winner, Karl Landsteiner investigated many of the 
fundamental principles of immunochemistry using an elegant molecular level approach to 
understanding antibody recognition (Landsteiner 1962). He made extensive use of 
immunoprecipitation as a method to detect the binding of antibodies to antigens. 
Through the cross-linking of relatively large antigens and antibodies, precipitates would 
form. However, at the time, there was insufficient knowledge about large protein 
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structures, so he turned to the use of small molecules which had a defined chemical 
composition, yet were not capable of inducing an immune response. He found that these 
small molecules, haptens, could be covalently attached to a larger molecule (i.e., protein 
carrier) and thereby induce hapten-specific antibodies. He also noticed that 
immunoprecipitation of the hapten-carrier conjugates could be inhibited by using only the 
smaller haptenic monovalent molecules. This was because the haptens lacked the ability 
to cross-link the bivalent antibodies, which can typically occur with larger molecules that 
possess multiple antibody-binding epitopes. This led to the eventual realization that 
antibodies were capable of discriminating subtle differences in the molecular structure of 
the hapten. 
Landsteiner's work was extended by both Linus Pauling and David Pressman to develop 
the concept of an antibody binding pocket that was both complementary and shape-
selective to its hapten (Pressman and Grossberg 1968). Elvin Kabat's studies led him to 
conclude that antibodies could recognize structures as small as 370 Da (Kabat 1976). 
Today, a commonly used hapten in immunological studies is trinitrophenyl, a mere 212 
Da (Rittenberg and Pratt 1969). Further development came from Michael Heidelberger 
and Elvin Kabat in the evolution of immunology from a descriptive field into a 
quantitative chemical discipline. They advocated the precise quantification of antigen-
antibody interactions and performed pioneering studies using new physical chemical 
techniques to characterize antigen molecules. 
By exploiting the fact that antibodies reversibly bind haptens by non-covalent 
interactions, such as hydrogen bonds, Van der Waals forces, or electrostatic forces, 
quantitative assessments of affinity can be measured. The affinity, or strength of 
interaction between an antigen binding site on an antibody and a hapten, is described by 
the following reversible equation: 
ka 
Ab+H Ab-H 
K = ka I kd = [Ab-H] I [Ab] [H] 
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where [H] is the concentration of free hapten, [Ab] is the concentration of the free antigen 
binding site, [Ab-H] is the bound hapten concentration, ka is the forward (association) 
rate constant, and kd is the reverse (dissociation) rate constant. The ratio of kalkd is the 
equilibrium constant K, a measure of affinity, which is the ratio of the concentration of 
bound Ab-H (antibody-hapten) complex to the concentration of unbound antibody and 
unbound hapten. Based on this equation, high affinity antibodies strongly interact with 
the specific antigen, and tend to dissociate slowly; whereas the low affinity antibodies 
possess high dissociation rate constants, and/or low association rate constants (Steward 
1978). 
Affinity maturation and antigen binding site diversity 
For the purposes of making an immunochernical biosensor, high affinity antibodies are 
desirable. However, the immunogen alone (a combination of the epitope's structure and 
the form of the entire immunogen) is not responsible for inducing high affinity 
antibodies, but rather in the context of affinity maturation. Clonal selection promotes the 
preservation of high affinity antibody secreting cells initially through continued 
stimulation of the high affinity clones as the immunogen concentration falls. High 
affinity B cells will be selected because of their greater ability to bind to low 
concentrations of antigen. As circulating antigen continues to decline, only those B cells 
with receptors having the highest affinity will be able to compete for antigen in a process 
called antigen-driven selection, which continually shifts expression to higher affinity 
antibodies. Thus, immunizations with a high concentration of antigen will initially 
produce a larger repertoire of high and low affinity antibodies, while immunizations with 
a low concentration of antigen will initially select for only the high affinity antibodies. 
Each immunogen can initially elicit a large number of antibody secreting B cells. The 
germline repertoire that encodes the components of the binding sites for these cells 
undergoes the process of somatic recombination that rearranges the gene sequences, 
which results in a large variety of binding sites (Tonegawa 1983). Susumu Tonegawa 
earned a Nobel Prize (1987, nobelprize.org) for the discovery that the ability of B cells to 
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develop a broad repertoire of antibodies toward a virtually limitless diversity of antigens 
is governed by the gerrnline diversity of the immunoglobulin gene complex. 
Antigen binding sites are best explained within the context of the chemical structure of 
the antibody molecule which was elucidated by Rodney Porter and Gerald Edelman in 
the 50s and 60s earning them a Nobel Prize (1972, nobelprize.org). They determined that 
the monomeric antibody molecule was comprised of 2 heavy polypeptide (H, 50 kDa) 
chains and 2light (L, 25 kDa) chains and that these chains were arranged such that there 
are 2 antigen binding sites located at the ends of the variable regions and connected by a 
constant, non-antigen binding fragment (Figure 6). Each binding site arises from the 
arrangement of six distinct contact residues (3 per polypeptide chain) within adjoining 
framework regions that position these contact residues, or complementarity determining 
regions (CDRs). Genetically speaking, either chain, H or L, can arise from over a million 
different arrangements of a few hundred gene segments, thus producing over a million 
different antibodies (Schroeder 2006). This vast diversity is aided by both chains 
containing three distinct CDRs that are modified by high mutation rates if antigen-
specific T cells are elicited. Ultimately, CDRs lie in close spatial proximity to one 
another within the binding site and provide a unique three-dimensional structure that is 
complementary to the antigen (Wu and Kabat 1970, Eisen 2001). 
Immunizations and mAb production 
Typically, antibodies are only synthesized in vivo. With advances in cancer research, 
methods for the production of immortal B cell lines (hybridomas) have greatly facilitated 
the large-scale isolation, selection and production of highly specific (monoclonal) 
antibodies in vitro. From an immunochemical standpoint, an antiserum represents the 
sum total of antibodies from potentially tens to hundreds of different B cells with 
different gerrnline rearrangements, each uniquely recognizing specific aspects or even a 
single epitope (or hapten) (Figure 7). Similar to any immunogen possessing a large 
variety of epitopes, in a synthesized immunogen, not only will the carrier molecule, the 
linking structure, as well as the desired hapten be targeted. In addition, this diversity of 
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Figure 6. A schematic of a classical monomeric antibody molecule illustrating the 2 H 
and 2 L chains, the variable and constant domains within each, and the terminal antigen 
binding sites connected by non-antigen constant binding fragments. (Image taken from 
www. biology .arizona.edu/IMMUN 0 LOGY /tutorials/antibody/ graphics/antibody. gif) 
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Antibody A 
AntibodyB 
Figure 7. Antibody recognition diversity of the immune response. For my purposes, the 
desired type of antibody is "Antibody C" that solely recognizes the hapten. "Antibody 
A" is shown as recognizing the carrier molecule, while "Antibody B" binds the linking 
arm of the conjugate. (Image adapted from Vanderlaan et al. (1988).) 
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recognition will lead to cross-reaction with fairly unrelated antigens (Vanderlaan et al. 
1988) (Figure 7). These polyclonal collections of antibodies can shift within an 
individual and differ considerably between individuals. This variability detracts from 
their utility as a standard and precise analytical tool. Thus the goal of developing 
monoclonal antibodies (mAbs) to small molecules is to isolate a specific and high affinity 
B cell, which subsequently produces 'Antibody C' (Figure 7), recognizing only the 
hapten target. 
From a technical standpoint, polyclonal antibodies are less expensive and faster to 
produce, but in the long term considerable expense is saved by the possession of a single, 
high specificity antibody in virtually unlimited supply. Therefore, the development of 
mAbs, led by Kohler and Milstein (1975) in the 1970s, has eliminated the variability in 
molecular recognition that plagued analyses using polyclonal antibodies. Thus mAbs 
have become the preferred biological recognition molecule of the immunoassay. 
Briefly, mAbs are generated by immunizing a mouse with an immunogen, which can be a 
hapten attached to a carrier protein. Repeated immunizations over prolonged periods 
allow affinity maturation thus producing higher affinity antibodies targeting the hapten. 
Then the B cells, harbored within the spleen, are fused with "immortal" myeloma cells 
(fusion partners). The resulting fused cells are called hybridoma cells (Kohler and 
Milstein 1975). 
The crux of procuring the most specific antibody is the screening of these hybridoma 
cells while cloning them to insure monoclonality. The process entails the determination 
of specificity for a particular antigen. The determination of specificity can be 
accomplished by the employment of a cELlS A, via the use of various hapten analogue 
inhibitors to select the most specific antibody. 
Once a single hybridoma line has been selected and cloned, it can be grown in vivo by 
growth of cells in an ascites form, or in vitro within a culture flask (Harlow and Lane 
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1988) to produce large quantities of antibody. Purified mAbs become the biological 
molecular recognition molecule of the biosensor. 
Hapten production and protein conjugation 
When developing a hapten, preservation of important structural features of the target 
analyte is required. A wide variety of conjugation techniques are available depending on 
the chemical structure; size, polarity, and, more importantly, the available functional 
groups of both the carrier molecule and the hapten (Hermanson 1996). Although P AHs 
do not possess the functional groups needed for conjugation to a protein carrier (such as a 
free carboxyl), some functional derivatives are commercially available. In cases where 
suitable derivatives are not available, a variety of different synthetic strategies are 
available for preparation of functional derivatives. To this end, researchers have 
successfully conjugated PAH haptens to proteins (see Table 6 in Appendix A for a list of 
haptens and references). To determine specific recognition of the hapten, different carrier 
molecules are used for immunizations (i.e., keyhole limpet hemocyanin; KLH) as 
opposed to screening (i.e., bovine serum albumin; BSA) for reactivity. Figure 8 provides 
an example of a target analyte, functionalized hapten, and hapten-protein conjugate. 
The average number of haptens conjugated per carrier molecule can often be assessed by 
titrating the remaining functional groups (i.e., free amines) by the use of amine-reactive 
compounds such as TNBS (2, 4, 6-trinitrobenzene-1-sulfonic acid), which provides a 
spectroscopic signal proportional to its degree of conjugation (Habeeb 1966). Another 
technique, matrix-assisted laser desorption ionization-MS (MALDI-MS), can establish 
the approximate increase in the molecular weight of the carrier protein resulting from the 
addition of varying numbers of small hapten residues. The MALDI-MS analysis requires 
a relatively expensive instrument and some expertise to use it, but MALDI-MS has been 
demonstrated to be a more accurate tool for conjugate characterization because it has no 
solubility constraints, a high tolerance for impurities, and lacks dependence on hapten 
composition (Adamczyk et al. 1994 ). It can be used for BSA conjugate characterization, 
but not KLH because the BSA protein fraction is smaller and more homogeneous in 
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Analyte/hapten· 
BaP 
Functionalized hapten: 
BaP-COOH 
Conjugate: 
BaP-COOH-protein 
Figure 8. Examples of a target PAH analytelhapten, a functionalized hapten, and hapten-
protein conjugate. The amorphous shape of the conjugate represents a protein molecule. 
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molecular weight. Because MALDI-MS can differentiate between the addition of these 
approximately 200 Da haptens, the variation among the protein fraction's molecular 
weight must also be small. 
Sapidyne's KinExA Inline sensor 
The sensor employed in this project was the KinExA Inline sensor manufactured by 
Sapidyne Instruments (Boise, ID) (Figure 9). The flow cell is a small (-2 mm in 
diameter) clear tube equipped with a semi-porous membrane. It is positioned directly in 
front of the laser source and fluorescence detection meter. Polymethylmethacrylate 
(PMMA; Sapidyne) particles, or beads, are used and are transferred to the flow cell where 
they cannot pass through the membrane and thus provide the immobilized support. There 
are a total of fourteen reagent lines; a buffer reservoir, a waste receptacle, a syringe for 
mixing, an antibody reservoir, and any specific buffers needed for washing, leaving at 
least seven lines free for samples. Pumps are used to move the fluid within the lines. 
The operational control is handled on a computer equipped with Inline Sensor software 
provided and designed by Sapidyne. The collected data is reported as a voltage change 
from the voltage reading at the start of a run of one sample to the end and referred to as 
the delta V (~ V). A typical biosensor run is essentially similar to a cELISA where the 
reduction in signal is inversely proportional to the concentration of the target in a sample 
(Figure 9, bottom right). It has been shown by Bromage et al. (2007a) that the detection 
limit of the KinExA Inline biosensor is lower than the detection limit determined by 
ELISA. 
Benefits of environmental assessment of PAHs 
Each petroleum source has a unique chemical fingerprint and thus authorities have been 
able to link petroleum releases with specific sources and/or the offenders. In particular, 
because of the uniqueness of sulfur heterocycles, sulfur fingerprints have been shown to 
be a valuable aid in petroleum characterization and source correlation (Mackenzie and 
Hunter 1979). Therefore, it is the goal of this research to generate antibodies specific to 
the 2- and 3-ring sulfur heterocycles. Furthermore, these antibodies will possess different 
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Figure 9. The top left picture is the KinExA Inline sensor from Sapidyne Instruments 
(Boise, ID) with the front panel removed. The middle is a schematic of its fluidics, 
courtesy of Dr. Bromage. The bottom diagram illustrates the flow cell and how the 
signal is inversely proportional to the PAH concentration. 
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cross-reactivity patterns than antibodies previously developed to the larger PAHs. This 
may also exclude the possibility of cross-reacting with a large majority of similar PAHs 
as the small size of the analyte will exclude detection of the larger compounds. 
It would also be desirable to have a single instrument that could perform multiple 
immunoassays simultaneously. This could provide a broad-spectrum, yet differential 
analysis, by incorporating antibodies with specificities to, for example, the higher 
molecular weight PAHs, and the lower molecular weight heterocycles. Multi-analyte 
detection has been demonstrated for the KinExA Inline biosensor with high 
reproducibility (Bromage, personal communication). 
If the technology were available, programs could be designed to provide cheap, rapid, 
and dependable assessments required for clean-up efforts. Physical actions, such as 
weather, wave, currents, and the addition of dispersants can influence the mixing rates of 
petroleum into water. Linking the biosensor with devices to estimate flow rates, would 
make it possible to model the direction and rate of movement of the spill. Because more 
samples can be collected and analyzed than by laboratory-based methods, a sampling 
scheme can be used to span the entire exposure area as well as water-column depths. In 
all, the rapid quantification of petroleum can be used to verify the cleanup activity, 
determine the necessary actions, and streamline the amount and type of resources needed 
for such efforts. 
Other uses of a field-deployable, rapid petroleum biosensor tool would be to monitor oil 
wells while drilling is underway. If a leak occurs, it can go unnoticed if the oil drilling is 
in a remote location (in deep seawater, under an ice sheet, etc.). If petroleum biosensors 
were in place, the early detection of the leak would allow for faster response times. 
Faster response times could enable effective salvaging of the leaking resource as well as 
reducing the amount of oil that enters the environment, both an advantage for the oil 
industry and the environment. The methods developed to analyze small, hydrophobic 
molecules could be applied to pesticides, pharmaceuticals, or any other contaminants, 
which are currently being measured by traditional analytical techniques. 
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RATIONALE AND OBJECTIVES 
The overall goal of this research was to develop a biosensor for the detection of 
petroleum-derived thiophenes in aquatic environments. In order to accomplish this goal, 
1) anti-dibenzothiophene mAbs were generated, 2) the mAbs were integrated into the 
KinExA Inline sensor format and validated, and 3) the KinExA Inline biosensor was 
employed in near real-time sampling applications. 
To accomplish Objective 1, first, a carboxylic acid derivative of the target contaminant 
was synthesized and subsequently conjugated with a protein carrier. Immunizations with 
the conjugated carrier were carried out until a satisfactory response was induced. MAbs 
were then produced, purified and extensively characterized with respect to affinity and 
cross-reactivity. 
To accomplish Objective 2, the antibodies were evaluated with the sensor instrument in a 
number of different environmental matrices to determine the sensitivity, accuracy, and 
precision of the biosensor under realistic conditions. A series of experiments were 
conducted to determine the effects of salinity, dissolved organic carbon (DOC) 
concentrations, and natural water sources on the performance of the biosensor. 
The biosensor was then evaluated for near real-time sampling to complete Objective 3. 
This was accomplished in the form of a laboratory-based time-series experiment where 
the concentration of contaminant decreased over time. Field-based applications were 
made when potential PAR-contaminated sites were identified and accessible. Validation 
of the biosensor results was made by comparison of results with those obtained by 
standard HPLC and/or GC-MS methods. 
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MATERIALS AND METHODS 
All reagents were of analytical grade and purchased from either Fisher Scientific 
(Pittsburgh, PA, USA), VWR (Bridgeport, NJ, USA), or Sigma-Aldrich (St. Louis, MO, 
USA) unless otherwise stated. 
Hapten synthesis and validation 
Haptens were synthesized to contain a carboxylic acid to provide a means for conjugation 
to protein carriers. All haptens, along with their abbreviations, are shown in Figure 10. 
dibenzothiophene-4-acrylic acid- The two-step synthesis of dibenzothiophene-4-acrylic 
acid (DBTAA) began with preparing 4-lithiodibenzothiophene via a reaction of 
dibenzothiophene (98%, Alfa Aesar, Ward Hill, MA, USA) with n-butylithium by the 
method of Kuehm-Caubere et al. (1996), then this mixture was treated with 3. 7 
equivalents of anhydrous N, N-dimethylformamide (DMF, Arcos Organics, Morris 
Plains, NJ, USA) at -70 oc. The resultant mixture was warmed to room temperature and 
stirred for 12 hours. The reaction was quenched with an excess of diluted HCl, the 
product was extracted into dichloromethane (DCM; Burdick & Jackson, Muskegon, MI, 
USA) and the solution was evaporated to dryness. The carbonyl products were isolated 
by TLC on silica gel using 2,4-dinitrophenylhydrazine for visualization. 
The Doebner-Knoevenagel reaction was employed for the preparation of the acrylic acid; 
this reaction has been reviewed by Johnson (1942). A mixture of the previously 
synthesized dibenzothiophene-4-carbaldehyde (186.3 mg, 0.87 mmol) and malonic acid 
(192.5 mg, 1.85 mmol) plus two drops of piperidine in anhydrous pyridine (6 ml) was 
refluxed for 90 minutes and then poured over a mixture of ice and HCI to yield a 
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Synthesized haptens 
0 OH 
HoyJ)j 
dibenzothiophene-4-acrylic acid 
DBTAA 
0 
benzothiophene-5-acrylic acid 
BT5AA 
0 
~OH 
thiophen-2-ylacrylic acid 
2TAA 
0 
0 
s~OH 
thiophen-3-ylacrylic acid 
3TAA 
0 
~OH 
5-methyl-2-thiopheneacrylic acid 
5M2TAA 
0 
2-methylfluorene-9-ylideneacetic acid 
2MF9AA 
3-methylfluorene-9-ylideneacetic acid 
3MF9AA 
Commercially available haptens 
~OH 
0 
2-benzo[b )thiophen-3-ylacetic acid 
BT3AA 
0 
,S~OH 
\J 
thiophene-2-propionic acid 
2TPA 
(Ys5oH 
~ 
3-methylbenzo[b ]thiophene-2-acetic acid 
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Figure 10. Structures of all haptens used throughout this investigation. The capitalized 
abbreviations below the chemical name are used throughout the text. The headings above 
the groups indicate how the hapten was obtained. The synthesized haptens are described 
in the text. 
32 
crystalline solid, which was then collected by vacuum filtration through filter paper, 
washed with approximately 20 rnl of water and allowed to air dry. 
Both compounds were characterized by melting point determinations, proton nuclear 
magnetic resonance eH NMR) and GC-MS. The 1H NMR studies were carried out on a 
Varian Mercury VX-400 (Palo Alto, CA, USA) employing samples dissolved in 
deuterochloroform containing 0.03% (v/v) tetramethylsilane as the internal standard. 
GC-MS was performed on a Varian 4D GC-MS-MS ion trap spectrometer (Walnut 
Creek, CA, USA) operated in electron ionization mode over a mass range of 100-500 
m/z. The GC was a Varian 3800 and the temperature program was as follows: initial 
temperature 75°C, hold for 1 minute, 4°C/minute to 350°C and hold for 0.25 minutes. 
benzothiophene-5-acrylic acid- The synthesis of benzothiophene-5-acrylic acid 
(BT5AA) employed the Doebner-Knoevenagel reaction as described above for DBTAA 
with the following modifications. The starting material was 1-benzothiophene-5-
carbaldehyde (230 mg, 1.4 mmol; Maybridge, England, 95% ). Recrystallization from hot 
ethanol yielded the product as yellowish brown crystals (170 mg, 59.0% yield). The 
product was characterized by 1H NMR, GC-MS, and melting point determinations. 
thiophen-2-ylacrylic acid- The syntheses of thiophen-2-ylacrylic acid (2TAA) employed 
the Doebner-Knoevenagel reaction as described above for DBTAA with the following 
modifications. The starting material was 2-thiophenecarboxaldehyde (1.0 g, 8.9 mmol; 
Aldrich, 98%). Recrystallization from hot ethanol yielded the product as yellowish 
brown crystals (740 mg, 53.3% yield). The final product was characterized by 1H NMR, 
GC-MS, and melting point determinations. 
thiophen-3-ylacrylic acid- The syntheses of thiophen-3-ylacrylic acid (3TAA) employed 
the Doebner-Knoevenagel reaction as described above for DBTAA with the following 
modifications. The starting material was 3-thiophenecarboxaldehyde (290 mg, 2.6 mmol; 
Aldrich, 98% ). Recrystallization from hot ethanol yielded the product as light tan 
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colored crystals (360 mg, 90.0% yield). The final product was characterized by 1H NMR, 
GC-MS, and melting point determinations. 
5-methyl-2-thiopheneacrylic acid- The syntheses of 5-methyl-2-thiopheneacrylic acid 
(5M2TAA) employed the Doebner-Knoevenagel reaction as described above for DBTAA 
with the following modifications. The starting material was 5-methyl-2-
thiophenecarboxaldehyde (530 mg, 4.2 mmol; Aldrich, 98%). Recrystallization from hot 
ethanol yielded the product as dark brown colored crystals (410 mg, 58.0% yield). The 
final product was characterized by 1H NMR, GC-MS, and melting point determinations. 
2-methylfluorene-9-ylideneacetic acid- In a two-step procedure, first, the generation of 
2-methylfluorenone was completed following the procedure of Snyder and Werber 
(1950) with minor modifications. In a typical procedure, polyphosphoric acid (1.4 g; 
Arcos Organics, 84%) was warmed in an oil bath prior the addition of 4-methyl-2-
biphenylcarboxylic acid (500mg, 2.4 mmol; Aldrich, 97% ). Additional polyphosphoric 
acid (1.2 g) was then added, the mixture was allowed to cool, and then hydrolyzed by the 
addition of ice and water. The solution changed from orange to yellow with yellow 
crystals forming as the final product. 
The method described by Goehring (1994) was employed for the synthesis of 2-
methylfluorene-9-ylideneacetic acid (2MF9AA). Under a blanket of nitrogen gas, 
sodium hydride (61 mg, Arcos Organics, 60%) was washed 3 times with hexane and 
suspended in anhydrous tetrahydrofuran (THF; 1 ml; Arcos Organics, 99.9%). 
Triethylphosphonoacetate (348 mg; Sigma) was dissolved in THF (500 !11), added slowly 
to this solution and stirred magnetically. 2-Methylfluorenone (250 mg, 1.3 mmol) was 
dissolved in THF (1 ml) and added slowly to the reaction. Once the reaction was 
complete, the mixture partitioned between water and DCM. The DCM fraction was 
collected. Water was removed from it with anhydrous sodium sulfate and the solution 
was evaporated leaving a yellow crystalline product. This ester product was then 
hydrolyzed in 5M NaOH (293 !11), acidified and extracted with ether and water. The 
aqueous phase was collected and yellow crystals formed following the addition of 
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concentrated HCL The solid was collected by vacuum filtration and allowed to air dry 
over night (150 mg, 0.64 mmol, 48.9% yield). The final product was characterized by 1H 
NMR, GC-MS, and melting point determinations. 
3-methyl.fluorene-9-ylideneacetic acid- In a three-step procedure, first, the generation of 
the diazonium salt of 2-amino-4-methylbenzophenone was accomplished following the 
procedure of Lipowitz and Cohen (1965) with modifications. A solution of 2-amino-4-
methylbenzophenone (250 mg, 0.001 mol; Aldrich, 99%) and 50% tetrafluoroborate (640 
mg, Arcos Organics) in 5.9 ml of ethanol was cooled below ooc. To this solution, a 
solution of sodium nitrite (89.6g, 1.29 mmol, Sigma) was added and the mixture was 
allowed to sit for 30 minutes. Cold ether (23.6 ml) was then added and again the mixture 
kept cold for 30 minutes giving a precipitate. Filtration and washings with cold ether 
afforded a white powder of the diazonium fluoroborate salt. 
Decomposition of the diazonium fluoroborate into 3-methylfluorenone was completed as 
described in Lewin and Cohen (1967). To the entire previous white powder product, 100 
ml of 0.1 N sulfuric acid was added and the solution was heated at 45°C until the powder 
dissolved. Cuprous oxide (125.4 mg, 0.88 mmol, Arcos Organics, 97%) was added. The 
red powder gradually turned blue. The reaction time for the cuprous oxide catalyzed 
reaction was approximately 2 hours. The product was filtered to remove the copper and 
extracted three times with DCM. Water was removed from the DCM solution by the 
addition of anhydrous sodium sulfate and the solution was evaporated leaving a dark 
amber brown colored thick viscous material (42 mg, 18.3% yield). 
Conversion of the previously synthesized 3-methylfluorenone to 3-methylfluorene-9-
ylideneacetic acid (3MF9AA) was completed as described above following the method of 
Goehring (1994). The final product was characterized by 1H NMR, GC-MS, and melting 
point determinations. 
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Other haptens employed 
A few commercially available haptens were employed, such as: 3-
methylbenzo[b]thiophene-2-acetic acid (3MBT2AA; Alfa Aesar, 97%), 2-
benzo[b]thiophen-3-ylacetic acid (BT3AA; Maybridge, England), and 2-thiophene 
propionic acid (2TPA). Other haptens used were obtained as gifts from Dr. Harris: 
biphenyl-2-ylacrylic acid (2BIPAA) and biphenyl-4-ylacrylic acid (4BIPAA; 
commercially available as 4-phenylcinnamic acid, Alfa Aesar, 98%; or in the reduced 
form of 4-biphenylacetic acid; Aldrich, 98% ). All hapten structures, along with their 
abbreviations, are shown in Figure 10. 
Antigen and immunogen preparation 
Hapten activation 
The activation of the haptens, the carboxylic acid derivatives of the target molecules, 
(i.e., DBTAA, BT5AA, 2TAA, 2TPA, 3TAA, 5M2TAA, 2MF9AA, 3MF9AA, 
3MBT2AA, BT3AA, 2BIP AA, and 4BIP AA), and their subsequent conjugations to a 
carrier protein were carried out by the method described by Singh et al. (2004), with 
minor modifications. Briefly, the hapten was dissolved in anhydrous DMF to a final 
concentration of 0.3 M along with equimolar amounts of N-hydroxysuccinimide (Pierce, 
Rockford, IL, USA) and dicyclohexylcarbodiimide (Pierce). The solution was rotated at 
room temperature until a visual precipitate of dicyclohexylurea had formed, usually 
between 20 to 60 minutes. The precipitate was removed by centrifugation at 5,000 x g 
for 5 minutes at room temperature; the supernatant contained the activated hapten. 
Protein conjugation 
Activated derivatized haptens were conjugated to a variety of carrier proteins (e.g., KLH, 
BSA, ovalbumin (OVA), and thyroglobulin (Thyro) ). All of the haptens shown in Figure 
10 were conjugated to both KLH and BSA. Typically, the hapten-KLH complex was 
used for immunizations, while the hapten-BSA complex was employed in the ELISA for 
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anti-hapten detection. Additionally, 4BIPAA was conjugated to Thyro such that when 
the 4BIPAA-BSA conjugate was used as the immunogen, the 4BIPAA-Thyro conjugate 
was used as the screening antigen. Likewise, when the 4BIP AA-Thyro conjugate was 
used as the immunogen, the 4BIPAA-BSA conjugate was used as the screening antigen. 
The following haptens were also conjugated to OVA; 2T AA, 2TPA, 3TAA, 5M2T AA, 
and4BIPAA. 
Hapten to KLH conjugation 
Hapten-KLH conjugates were produced by first mixing 3.5 111 of the activated derivatized 
hapten (0.3 M) into 250111 ofDMF and then added to 1ml ofKLH (-5 mg/ml, -2.5 nM 
in manufacturers' phosphate buffered saline (PBS), pH 7.4), resulting in approximately a 
400: 1 ratio of hapten to KLH. The reaction mixture was rotated for 2 hours at room 
temperature to complete the conjugation. The conjugate was then dialyzed against PBS 
(1.85 mM NaHzP04, 8.41 mM NazHP04, 150 nM NaCl, pH 7.4) with three 1 L changes 
at room temperature over 24 hours. The conjugate was filter-sterilized through 0.22 11m 
filters and a final protein concentration was determined by bicinchoninic acid protein 
assay (BCA, Pierce), read on a microtiter plate reader (MTX Lab Systems, Vienna, VA, 
USA) using a 540 nm filter. 
Hapten to BSA conjugation 
To improve the efficiency of conjugation, varying amounts of DMF solvent were added 
to two different buffer solutions. In all, six DBTAA-BSA conjugates were made, three in 
PBS (pH 7.4) and three in borate buffer (50 mM boric acid, pH 9.0). Aliquots (5 ml) of a 
20 mg/ml BSA solution, three for each buffer type, were placed in separate tubes. The 
concentration was adjusted to 10 mg/ml BSA (1.5 Jlmol) with the addition of the 
appropriate amount of DMF and/or buffer, such that the final solutions contained 
approximately 0%, 25% or 50% DMF. Activated DBTAA hapten (50 Jll, 15 11mol) was 
added in aliquots to each BSA solution resulting in a molar ratio of 10:1 of hapten to 
BSA. If the solution began to tum opaque, indicating protein precipitation, the addition 
of the activated hapten was terminated. As with the KLH conjugation, the BSA reaction 
mixtures were rotated, dialyzed, sterile-filtered, and quantified as described above. 
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The DBT AA-BSA conjugates were analyzed by MALDI-time-of-flight MS, similar to 
that described elsewhere (Adamczyk et al. 1994 ), employing a Voyager Elite DE 
instrument (Perseptive Biosystems, Ramsey, MN, USA) at the Vanderbilt Mass 
Spectrometry Resource Center operating in the positive ion mode using 3-
hydroxypicolinic acid matrix containing ammonium hydrogen citrate (7 mg/ml) to 
suppress sodium and potassium adducts. The spectra were calibrated using a native BSA 
(MW 66 kDa). The average number of bound DBT AA molecules (MW 254 Da) was 
calculated according to the equation: [(MWconjugate- MWprotein) I MWhapten]. 
Hapten to BSA, OVA, and Thyra conjugation 
Following the results obtained from the above experiment, hapten-BSA, -OVA, and 
-Thyro conjugates were produced by first mixing 50 J.Ll of the activated hapten (0.3 M) 
into 100 J.Ll of D MF and then added drop wise to 10 ml of protein ( -10 mg/ml, in PBS 
with 25% DMF), resulting in approximately a 10:1 ratio of hapten to protein. If the 
solution began to tum opaque, indicating protein precipitation, the addition of the hapten 
was terminated. As per the KLH conjugation, the reaction mixtures were rotated, 
dialyzed, sterile-filtered, and quantified as described above. 
Animals and immunization routines 
All animal studies were conducted in accordance with the guidelines established by the 
College of William & Mary's Institutional Animal Care and Use Committee. Typically, 
three to seven (6 week old) female BALB/c mice were immunized by intraperitoneal 
injection of 100 J.Ll of a 1:1 Freund's complete adjuvant emulsion containing 50 J.Lg of 
hapten-carrier. All haptens (DBTAA, BT5AA, 2T AA, 2TPA, 3T AA, 5M2T AA, 
2MF9AA, 3MF9AA, 3MBT2AA, BT3AA, 2BIPAA, and 4BIPAA) were employed for 
immunizations. Typically the carrier protein was KLH, except in the additional 
experiments where 4BIPAA was conjugated to BSA and Thyro as the carrier protein. 
Two subsequent immunizations were administered at 4 week intervals with the same 
conjugate concentration emulsified 1:1 in Freund's incomplete adjuvant. 
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Monoclonal antibody production 
Mice exhibiting the desired serum antibody specificity and selectivity (determined by the 
screening methods described in the subsequent sections) were given a final booster 
injection 3 to 5 days prior to the fusion procedure (Harlow and Lane 1988). Briefly, a 
10 J..tg dose of hapten-KLH was diluted with PBS to a total volume of 200 J..tl, with 100 J..tl 
of it administered intravenously, while the other 100 J..tl was given intraperitoneally. 
Splenocytes were isolated and fused with SP2/0 myeloma cells using the 50% 
polyethylene glycol method as described by Harlow and Lane (1988). The resulting cells 
were distributed into ten 96-well tissue culture plates (Costar, Coming, NY, USA) at 150 
J..tllwell. 
After visible colonies had formed, the plates were screened via ELISA using a 96-pin 
replicator (Fisher) to sample culture supernatant. Additionally, for the DBT AA fusion, a 
cELISA was employed using dibenzothiophene as the inhibitor. This was performed by 
pre-loading DBTAA-BSA coated plates with a solution of the inhibitor at 1 J..tg/ml in 100 
J..tl of PBS prior to the introduction of hybridoma supernatants. Hybridoma supernatants 
were added to the wells and compared to the wells without inhibition. Those hybridomas 
from wells demonstrating significant inhibition were selected for clonal expansion. 
Positive hybridomas were cloned (3 times) by limiting dilution (Harlow and Lane 1988). 
Stock mAbs were produced from ascites of pristane-primed male mice injected with the 
cloned hybridoma (NRC 1999). Ascitic fluid was collected and purified using a Melon® 
Gel Monoclonal IgG Purification Kit (Pierce). The isotype classification was determined 
by Mouse Typer® Sub-lsotyping Kit (BioRad, Hercules, CA, USA). MAb protein 
concentration was determined by BCA and the purity was confirmed by running a 12% 
sodium dodecyl sulfate poly-acrylamide gel electrophoresis (Harlow and Lane 1988) 
followed by Silver Staining (Sigma-Aldrich). MAb stocks were stored at 1 mg/ml 
concentration in PBS with 50% glycerol at -20°C until used. 
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Magnetic bead isolation 
A large excess of irrelevant hybridomas are produced during a fusion. In an attempt to 
procure the few valuable clones, preselection of hapten-specific splenocytes via magnetic 
panning was performed (Steenbakkers et al. 1993). Paramagnetic beads (Dynal M-450, 
epoxy activated; Invitrogen) were coated with 4BIPAA-BSA and cell isolation was 
conducted according to the manufacturer's method. After the splenocytes from a 
4BIPAA-KLH immunized mouse were isolated, the beads were incubated with the cell 
suspension for 30 minutes at 4 oc with occasional tilting and rotation. The solution was 
subjected to a magnet and the supernatant was drawn off. Both the magnetic bead-bound 
cells and those cells in the supernatant were fused separately, as described above. 
Antibody characterization 
ELISA plate preparation 
For sera, supernatant and mAb screening, 96-well microtiter plates (Costar) were coated 
for 1 hour at room temperature with 100 J.!llwell of a hapten-BSA conjugate solution 
typically ranging from 0.1 to 10 J.!g/ml in sodium carbonate coating buffer (15 mM 
Na2C03, 35 mM NaHC03, pH 9.6). The plates were blocked with 200 J.!llwell of 0.5% 
BSA in Tween Tris buffered saline (TTBS; 0.1% Tween 20, 50 mM Tris, 1 mM EDTA, 
150 mM NaCl, pH 8.0) for 1 hour at room temperature. The plates were either used 
immediately, or the blocking solution was removed and the plates stored at -20°C until 
required. 
Titration screening assays 
Prior to each immunization, the mice were bled from the tail vein for antibody titer 
determination using an ELISA procedure (Harlow and Lane 1988). All sera were 
screened against a plate coated with the same hapten-BSA conjugate, as described above. 
Sera were serially diluted in PBS (as opposed to TTBS, to maintain diluent consistency 
with that which was required in competitive inhibition assays described later), loaded at 
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100 J.tllwell and placed on a rocker for 1 hour at room temperature. The plates were 
washed with 3 rinses of TTBS. A goat anti-mouse IgG secondary antibody conjugated 
with horseradish peroxidase (Jackson Immunoresearch, West Grove, PA, USA) was used 
at 0.25 J.tglml in PBS, loaded at 100 J.tllwell and placed on a rocker for 1 hour at room 
temperature. The plates were washed again, developed using a solution containing 7. 7 
J.tmol of 2,2'-azino-bis(3-ethylbenzthiazoline-6-sulfonic acid) (Calbiochem, Gibbstown, 
NJ, USA), 10 J.tl of 30% H20 2 in 10 ml of citrate buffer (lOmM citric acid, pH 4.0), and 
read on a microtiter plate reader using a 405 nm filter. The maximum rate of reaction 
(mOD/min) was calculated using the Deltasoft JV software (BioMetallics, Princeton, NJ, 
USA) and determined for each sample. The antibody titer (activity units per ml) was 
determined by the amount of sera required to generate a response of 50% of the 
maximum rate. 
Hapten-specific titers, as determined by the above ELISA, were compared to protein 
carrier-specific titers by screening sera from 5M2TAA-, BT3AA-, 4BIPAA-, and 
2MF9AA-KLH immunized groups against KLH. Plates were coated with 1 to 5 J.tglml of 
KLH, following the microtiter plate coating method described above. 
For hapten titer screening of the 4BIPAA-BSA group, 10 J.tg/ml of 4BIPAA-Thyro was 
coated onto the microtiter plate as described above, except blocked with only TTBS; 
0.5% BSA was not added to the blocking solution. Likewise, for carrier protein titer 
determinations, mice immunized with 4BIPAA-BSA were screened against 5 mg/ml of 
BSA, and those immunized with 4BIPAA-Thyro were screened against 5 mg/ml of 
Thyro. 
To explore heterologous hapten specificity (i.e., activity towards a hapten not used in the 
immunization), sera from BT3AA-KLH immunized mice were screened against BT5AA-
BSA conjugate. 
The addition of thiomersal to the diluent was examined because of its use as a 
preservative. MAb 7B2.3 was employed in a titration ELISA to assess thiomersal affects. 
41 
Checkerboard assay 
A checkerboard titration was completed in order to establish the optimum working 
dilutions of the coating antigen and the antibody for ultimately detecting various 
inhibitors (e.g., PARs) in solution with the highest sensitivity. Plates were coated and 
blocked in the same format as described above, except that they were coated with the 
hapten-protein conjugate using a two-fold dilution series across the plate in duplicate 
with the first two columns at approximately 2 J.Lg/ml. MAb or sera was then titrated 
down each column. Based on each titration, the coating concentration was selected that 
resulted in a quantifiable signal response and its corresponding antibody concentration at 
about 50% of the maximum signal response. 
Competitive inhibition assays ( cELISAs) 
All cELISAs were conducted employing a specified inhibitor at a soluble concentration 
with serial dilutions of that concentration in PBS* containing 5% methanol to ensure 
inhibitor solubility. Control wells contained only PBS with 5% methanol, to which the 
response was normalized. First, coated ELISA plates were loaded with 50 J.Lllwell of 
each inhibitor concentration. The sera or mAb was then loaded at 2X strength in 50 
J.Lllwell such that lX was the concentration optimally determined above by the 
checkerboard titration. The plates were washed, incubated with the secondary antibody, 
washed again, and developed as described above. 
The inhibitors chosen for each assay varied depending on the goal of the experiment. 
For a typical sera screening, the inhibitors chosen were those with a similar structure to 
that of the hapten, without the carboxyl group and its carbon chain linking arm. For 
example, for the sera generated to hapten BT3AA, benzothiophene was used as the 
inhibitor. For the sera generated to hapten 4BIPAA and 2BIPAA, biphenyl was used as 
the inhibitor. Table 2 provides an illustration of the derivatized haptens employed along 
with the P AH it was meant to represent. 
* TTBS was avoided, because it contains Tween, which interacts with hydrophobic analytes, competing 
with the antibody and therefore less analyte is available to cause inhibition (Manclus and Montoya 1996). 
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Table 2. lllustration of structural similarities of derivatized haptens and target analytes. 
Derivatized hapten(s) Target analyte 
0 0 
0 
~OH s~OH ~OH 0 
2TPA thiophene 2TAA 3TAA 
0 s ~OH v 
5M2TAA methyl-thiophene 
yJ)j ~ j co HO OH j 0 0 benzothiophene BT5AA BT3AA 
o=YOH ex< j j 
methyl-benzothiophene 
3MBT2AA 
0 OH 
s 
=- 0Z) s 
--= ~ 
~ ~ ~ /; dibenzothiophene 
DBTAA 
0 0 
aD OOH y I~ OH ~ ~ ~ ~ I .#" 
.#' .#' 
2BIPAA 4BIPAA biphenyl 
0 0 
du- dzz C)':Q ~ ~ /;:: ~ ~ /;:: methy 1-fluorene 
2MF9AA 3MF9AA 
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In one scenario, a cELISA was conducted employing a heterologous hapten assay format. 
Sera from BT3AA-KLH mice were assessed on a plate coated with BT5AA-BSA and 
inhibited by benzothiophene. This was compared to the inhibition profile produced when 
the same sera was assessed on a plate coated with its homologous hapten BT3AA-BSA 
inhibited by benzothiophene. 
Additionally, some sera were analyzed to provide a recognition profile of other PAHs. 
For example, 4BIPAA-KLH sera were employed in a cELISA with the following 
inhibitors: pyrene (Aldrich, 99% ), naphthalene, phenanthrene (ICN Pharmaceuticals Inc, 
Plainview, NY, USA), biphenyl, and anthracene (J. T. Baker, Phillipsburg, NJ, USA, 
99%). 
Specificity of 2MF9AA-KLH sera were examined using the following inhibitors: 
anthracene, phenanthrene, benzo[a]anthracene (Pfaltz Bauer, Stamford, CT, USA), 9,10-
dimethylbenzanthracene, 7, 12-dimethylbenzanthracene, 9, 1 0-dimethylanthracene, 3,6-
dimethylphenanthrene, 2,3,5-trimethylnaphthalene, 1 ,4,5-trimethylnaphthalene, 1,3-
dimethylnaphthalene, 4-methyldibenzothiophene and 2-methylphenanthrene. 
The initial characterization of the DBTAA mAb, 7B2.3, was conducted using 
unsubstituted PAHs and heterocyclic inhibitors ranging from 2 to 5 rings: anthracene, 
benzo[a]pyrene, benzo[a]anthracene, biphenyl, chrysene (Aldrich, 95%), dibenzofuran, 
dibenzothiophene, fluoranthene (Aldrich, 98%), fluorene (Aldrich, 98%), naphthalene, 
phenanthrene and pyrene; and the following alkylated PAHs and heterocycle: 9,10-
dimethylbenzanthracene, 7, 12-dimethylbenzanthracene, 9, 1 0-dimethylanthracene, 3,6-
dimethylphenanthrene, 2,3,5-trimethylnaphthalene, 1 ,4,5-trimethylnaphthalene, 1,3-
dimethylnaphthalene, 4-methyldibenzothiophene and 2-methylphenanthrene. 
The stormwater runoff samples (described later), were determined by GC-MS to contain 
other environmental contaminants, such as, triclosan, nonylphenol, bisphenol-A, and 
caffeine. As such, these compounds were used as inhibitors of 7B2.3 in a cELlS A. 
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After evaluation of the toxicological study (described later), it was suspected that 
phenanthrene metabolic products might be detected during biosensor analysis. To assess 
7B2.3 specificity, a standard solution containing the putative oxidation product of 
phenanthrene (!-hydroxy-phenanthrene, Dr. Ehrenstorfer GmbH, Augsburg, Germany, 
99%) was evaluated on the biosensor. 
Biosensor development 
Features and principles of the KinExA Inline sensor (Sapidyne) have been described 
elsewhere (Darling and Brault 2004, Drake et al. 2004, Yu et al. 2005, Bromage et al. 
2007a). An attached laptop computer provided instrumental control, graphic signal 
output, and data storage. The immobilized antigen DBTAA-BSA was coated onto 
PMMA beads following previously described methods (Bromage et al. 2007b ). The 
specificity of 7B2.3 for 3- to 5-ring P AHs (refer to the mAb inhibition screening section 
in the Results section or Spier et al. 2009) was coupled to the fluorescent dye, AlexaFluor 
64 7 (Invitrogen, Carlsbad, CA, USA), following the manufacturer's protocol. An 
antibody concentration of 0.38 )lg/ml resulted in a voltage change of approximately 1 V. 
The speed in which an antibody comes to equilibrium with a sample is determined by the 
antibody's on and off rates. The k0 n, koff• and K for the antibody employed in the 
biosensor studies that follow, mAb 7B2.3, were determined using the Kinetics Direct 
methods employing the KinExA®3000 (KinExA®3000 Instrument Manual, Sapidyne) 
with slight modifications to the manufacturer's instructions. Essentially, concentrations 
of antibody and dibenzothiophene were held constant and the amount of time that they 
are mixed together (i.e., incubated) was varied and then assessed (voltage response 
recorded). 
The automated sample handling program (see Appendix B) was similar to others that 
have been described (Bromage et al. 2007b ). Briefly, for every sample, a new bead pack 
( -400 )ll) coated with antigen was loaded into the flow cell. Then, 400 )ll of 
fluorescently labeled 7B2.3 was pulled into the drawing syringe, followed by 400 )ll of 
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deionized water, a standard, or a sample. This mixture was pushed into and drawn out of 
a mixing syringe to complete mixing. Half of the solution was discarded to waste and the 
remaining 400 Ill was pushed over a previously loaded bead pack in the flow cell. For 
fluorescence detection, excitation and detection wavelengths were 620 and 670 nm, 
respectively. The resulting fluorescence signal was based on competitive exclusion by 
underivatized PAHs in the sample such that the amount of 7B2.3 bound to the antigen 
coated beads was inversely proportional to the concentration of 3- to 5- ring PAHs. A 
solution of 50% dimethylsulfoxide (DMSO) in deionized water was incorporated for line 
rinsing between each sample analysis to prevent cross-contamination of samples by 
residual PAHs. In total, quantitative assessments were obtained in approximately 3 
minutes, with 7 minutes for preparation and introduction of the next sample. Up to seven 
samples can be loaded for analysis with all further steps performed automatically. 
Calibration curves for the biosensor 
Several PAH formulations were evaluated for biosensor detection (signal response) and 
eventual use in the generation of a calibration curve. The formulations were SRM 164 7b 
Priority Pollutant PAHs (National Institute of Standards and Technology (NIST), 
Gaithersburg, MD, USA), SRM 2260 Aromatic Hydrocarbons in Toluene (NIST), a 
solution containing equal concentrations (by mass) of 6 PAHs (anthracene, chrysene, 
fluoranthrene, fluorene, phenanthrene, pyrene), and a solution of only phenanthrene. 
Each solution was diluted in deionized water such that they contained less than 1% of the 
original solvent. The calibration curves represent the sum of the PAH concentrations for 
the respective formulations. For each formulation standard, a five-point calibration curve 
within its linear range was used. 
Matrix effects 
As the desired utility of this biosensor technology was for the detection of hydrophobic 
PAH molecules, different amounts of organic solvents were examined to determine how 
they would affect the performance of the biosensor. PBS buffer solutions containing 5 
and 10% of the water miscible solvents, DMF, DMSO, methanol and acetone were 
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examined on the KinExA. The results were normalized to the antibody binding signal 
generated in a PBS buffer solution containing no solvent. 
Biosensor sampling of various water sources required the evaluation of matrix effects 
(i.e., effects of varying solute components on biosensor performance). Various water 
sources were anticipated to range from fresh to oceanic waters, therefore, salinities of 0 to 
38 ppt were evaluated. Hawaiian Marine Mix (HMM) was diluted in deionized water 
and salinities were assessed by a refractometer. These solutions of varying salinities 
were assessed to determine the effect on biosensor function. Solutions of varying salinity 
were spiked with two different concentrations of phenanthrene, 1 J.Lg/1 and 3.1 J.Lg/1, and 
the effect on the PAH detection assessed. Additionally, filtered (5 J.Lm) York River water 
and PBS were also spiked with 1 J.Lg/1 phenanthrene so that the impact of a natural water 
source on biosensor function could be assessed. Similarly, dilutions of humic acid 
(dissolved organic carbon; DOC) were spiked with 2.0 J.Lg/1 of phenanthrene to determine 
if DOC interfered with P AH quantification. 
Biosensor environmental applications 
Site description and sample collection 
The biosensor was employed in four different contexts; 1) LA Clarke & Son EPA 
Superfund site in Spotsylvania, VA, USA (groundwater monitoring), 2) Money Point site 
in the southern branch of the Elizabeth River near Norfolk, VA, USA (estuarine 
monitoring), 3) Seawater Research Laboratory at the Virginia Institute of Marine Science 
(VIMS), Gloucester Point, VA, USA (laboratory toxicological study), and 4) two road-
side drainage locations near VIMS (stormwater runoff monitoring). 
Groundwater monitoring 
The LA Clarke site was a creosote/coal tar wood treatment facility; which, as a result of 
50 years of operation, had contaminated the groundwater with P AHs, benzene, and dense 
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non-aqueous phase liquids. Eight wells from this site were selected based on historical 
data, which indicated they would provide a wide range of P AH levels. The sampling 
order was from less to more contaminated starting with W7, W5, MW81, D8, PWOl, D3, 
W6, and then MW80. The wells were purged prior to sampling, and then 30 m1 of water 
were collected in amber vials for biosensor analysis and 4 L were collected in amber 
bottles for GC-MS analysis. The apparent outdoor temperatures were below 5°C, which 
caused some fittings to leak. So, the biosensor was placed in the back of a heated sport 
utility vehicle and powered with an extension cord connected to an outlet in an on-site 
work shed. Samples taken for GC-MS analysis were kept cool until laboratory analyses 
could be performed. 
Estuarine monitoring 
The Elizabeth River Project, an independent, non-profit organization, has targeted the 
Money Point area of the Elizabeth River (Norfolk, Virginia, USA) as a remediation site. 
This site has severely PAR-contaminated sediments due to historical creosote releases 
(ERP 2008). Remediation efforts include dredging of contaminated sediments, capping, 
and wetland restoration. On June 9, 2009, while the dredging operation was underway, 
the biosensor was employed to monitor P AHs released into the surrounding water 
column. All samples were collected outside of a sediment curtain that enclosed the 
dredging activity. Water samples were collected in 30 m1 amber glass vials for on-site 
biosensor analysis and in 4 L amber glass bottles for laboratory-based GC-MS analysis. 
At this site, the biosensor was operated on board the 6-m vessel, RIV Oystercatcher. The 
biosensor was kept in the front cabin area and powered by a 12 V battery (Energizer 
E27RC Marine Battery; St. Louis, MO, USA) through a 110 V power inverter (Xantrex 
Xpower 1750 Plus; Vancouver, Canada). Ambient temperatures on board the vessel 
exceeded 3SOC at times, which deteriorated sensor performance; therefore, temperature 
was stabilized by placing ice chips in the reagent block. Biosensor samples were filtered 
and analyzed on-site, while the samples taken for GC-MS analysis were kept on ice until 
laboratory analyses could be performed. 
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Toxicological study 
The toxicological study was performed to monitor the phenanthrene dosing in an 
independent experiment. Zebrafish (Dania rerio) were held in 8 L freshwater aquaria 
with water temperature maintained at 28°C. Fish were exposed to phenanthrene at 2 
nominal concentrations, one at 150 )lg/1 and a second at 400 )lg/1, each with triplicate 
tanks. The tanks were fortified with phenanthrene every 12 hours and the water 
exchanged every 24 hours. Aliquots of water ( -1 rnl) were collected for biosensor and 
HPLC analyses from 4 tanks (2low and 2 high exposure tanks) prior to and post 
phenanthrene renewal. Samples were collected for 5 consecutive days. The biosensor 
samples were assessed at room temperature, while the samples taken for HPLC analysis 
were kept cool until laboratory analyses could be performed. 
Stormwater runoff study 
Two sites located near the VIMS campus were selected for monitoring during a rain 
event (April1-16, 2010). The first site was a retention pond located below the Coleman 
Bridge (CB; lat. 37° 14' 52", long. -76° 30' 9"). The second site was along the Yorktown 
Creek (YTC) where it passes under the George Washington Memorial Highway/ US 
Route 17 (lat. 37° 13' 55", long. -76° 30' 50") on the west side. Because the sites were 
sampled simultaneously and were close to the laboratory (i.e., -0.5 to 3 krn away), the 
samples were brought back to the laboratory for analysis. Samples were collected at each 
site every other day until it began raining, whereupon the samples were collected hourly. 
For biosensor analysis, triplicate water samples were collected in 30 ml vials; larger 
samples (1 L) were collected for GC-MS analysis when biosensor results revealed that 
PAH concentrations were rapidly changing. Cumulative rainfall readings from rain 
gauges stationed at each sampling site and the observation times were recorded. 
Analytical analysis of PAHs 
GC-MS analysis was conducted using previously described methods (Unger et al. 2008) 
with the following modifications. The estuarine samples were filtered using a 0.45 11m 
Teflon® filter (Millipore Corporation, Billerica, MA, USA) prior to analysis because of 
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high levels of suspended solids, which could potentially clog the biosensor lines. For the 
groundwater, estuarine, and stormwater runoff studies, 1 L of water sample was 
transferred to a pre-cleaned separatory funnel, spiked with surrogate standards (1,4-
dichlorobenzene-d4, naphthalene-ds, acenaphthene-d 10, phenanthrene-d 10, chrysene-d 12, 
perylene-d12, PCB 30, PCB 65, PCB 204, 1,1 '-binaphthyl, and perinaphthenone; Ultra 
Scientific, Kingston, RI, USA), and extracted three times with 40 m1 of DCM. The 
volume was reduced under a gentle stream of nitrogen using a Turbo Yap® evaporator 
(Zymark Corp., Hopkinton, MA, USA) and the internal standard p-terphenyl 
(ChemService, West Chester, PA, USA) was added. The extracts were analyzed on a 
Varian 3800 GC using a Varian CP-8400 Autosampler coupled to a Saturn 2000 
GCIMSIMS ion trap MS (Varian, Walnut Creek, CA, USA) operated in electron 
ionization mode (70 e V). It was equipped with a split/splitless injector maintained at 
320°C. The carrier gas was He and injections were made in splitless mode on a DB5, 60 
m x 0.32 mm x 0.25 f!m film thickness capillary column from J&W Scientific (Folsom, 
CA, USA). The GC temperature program was 75°C to 320°C at 4° C/minute with an 
initial hold of 1 minute. The MS trap, manifold, and the transfer line temperatures were 
220°C, 80°C, and 320°C, respectively. Scans were 100 to 500 m/z for 8 to 49 minute and 
then 100 to 650 m/z from 49 to 62.25 minute; selected ions were used to quantify the 
targeted analytes. Seven-point calibration curves and sample analyses of individual 
analytes were performed using the Varian MS Workstation software package, version 6.8 
(Varian). The limit of detection was approximately 0.01 f.tg/1 per analyte. Each set of 
extractions contained a laboratory blank and a replicate environmental sample. 
HPLC analysis of the toxicological samples followed a modified method from Unger and 
colleagues (Unger et al. 2007). The HPLC method was performed using a Thermo 
Separation Product (TSP; Riviera, FL, USA) SpectraSYSTEM P4000 Binary Gradient 
Pump, a TSP SpectraSYSTEM AS3000 Variable-Loop Autosampler with column oven, 
and a Waters 474 Fluorescent Detector. The gradient was 100% water to 20/80% 
water/acetonitrile (Burdick & Jackson) through a Restek Allure C18 column (5 f..Lm 
particle size, 250 x 4.6 mm; 60 A pore size; Restek Corp., Bellefonte, PA, USA). 
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Biosensor analysis of PAHs 
Most of the groundwater samples were run undiluted; the samples that exceeded the 
upper limit of quantitation (30 11gll) were diluted with deionized water and analyzed. The 
estuarine water samples were filtered (0.45 11m Teflon®; Millipore) prior to analysis. The 
samples from the toxicological study were diluted in deionized water prior to analysis to 
bring them into the quantification range of the biosensor. The filtration and dilution steps 
were completed in no more than 5 minutes. Sample analyses were completed within 30 
minutes of sample collection. The stormwater runoff samples were analyzed directly, 
without any manipulation. During the rain event, one to two of the triplicate samples 
were analyzed in near real-time (within 10 to 60 minutes of collection), to guide further 
sampling. The remaining samples were kept at 4 °C and analyzed within 3 days. 
Standards and blanks were routinely analyzed to ensure the performance of the 
instrument during each study. 
Statistical analyses 
The calibration curves, detection limits and biosensor linear range were determined by 
log-linear regression analysis. Error estimates of the biosensor method were determined 
by triplicate analysis of laboratory standards. During laboratory development of the 
biosensor methodology, the detection limit was determined by performing the EPA 
method detection limit procedure 40 CFR Part 136 Appendix B. During field studies, the 
limit of detection was defined as a signal-to-noise ratio of 3:1. The PAH concentrations 
determined by biosensor and GC-MS or HPLC methods were compared using a Pearson 
correlation coefficient (r) analysis. Deming (orthogonal) regression analysis was 
performed to examine the relationship between the biosensor and the GC-MS or HPLC 
method. All statistics were performed using Minitab vl6 software (Minitab, State 
College, PA, USA). 
51 
RESULTS 
Validation of synthesized haptens 
dibenzothiophene-4-acrylic acid- The synthetic pathway for the hapten DBTAA is 
shown in Figure 11A. TLC revealed the presence of two carbonyl compounds, the faster 
eluting compound was isolated as a colorless, crystalline solid (21% yield) and identified 
as dibenzothiophene-4-carbaldehyde on the basis of melting point, mass spectra and 1H 
NMR. M.p. 115-122°C (lit. m.p. 123-124°C, (Katritzky and Perumall990)); MW 
calculated for C13H8SO m/z 212.3; observed 212; 1H NMR: <i 10.31 (s, lH), 8.45 (dd, J = 
7.8 + 1.0 Hz, 1H), 8.24 (dd, J = 5.0 + 2.4 Hz, 1H), 8.01 (m, 2H), 7.69 (t, J = 7.5 Hz, lH), 
7.53 (m, 2H);. The NMR spectrum is consistent with that reported by Katritzky and 
Perumal for this compound which they had prepared by a different route (1990). 
The dibenzothiophene-4-carbaldehyde was used in the second step of the reaction 
sequence shown in Figure 11A. The final product was recrystallized from ethanol/water 
yielding colorless needles (109.6 mg, 49.4% yield) and identified as dibenzothiophene-4-
acrylic acid (DBTAA) on the basis of the mass and 1H NMR spectra. M.p. 249-253°C; 
MW calculated for C15HwS02 m/z 254.3, observed 254 (Figure llB); 1H NMR results 
are listed in Table 3, the carboxyl H was not observed. 
benzothiophene-5-acrylic acid- The synthetic pathway for BT5AA is shown in Figure 
12A. The product was identified as benzothiophene-5-acrylic acid on the basis of mass 
spectra and 1H NMR. M.p. 226-231 oc; MW calculated for C11H8S02 m/z 204.2; 
observed 204 (Figure 12B); 1H NMR results are listed in Table 3, the carboxyl H was not 
observed. 
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Figure 11. A) Synthesis of dibenzothiophene-4-acrylic acid (DBTAA). B) Mass 
spectrum of DBTAA. The signal at 254 is the molecular ion. 
53 
Table 3. NMR assignments for synthesized compounds. 
Compound name (abbr.) 
dibenzothiophene-4-acrylic acid 
(DBTAA) 
benzothiophene-5-acrylic acid 
(BT5AA) 
thiophen-2-ylacrylic acid 
(2TAA) 
thiophen-3-ylacrylic acid 
(3TAA) 
5-methyl-2-thiopheneacrylic acid 
(5M2TAA) 
Compound structure 
O OH 
~OH ~~ 
~OH \_~ 
0 
uJ'oH 
s 
0 
~H 
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H NMR: 
6.74(d, 1H,J 16.2Hz) 
7.52 (m, 3H) 
7.71 (d, 1 H, J=7.0 Hz) 
7.93 (m, 1 H) 
8.08 (d, 1 H, J=16.2 Hz) 
8.19(m,1H) 
8.22 (dd, 1 H, J=7.8+ 1.0 Hz) 
6.53 (d, 1 H, J=16Hz) 
7.38 (d, 1 H, J=6Hz) 
7.51 (d, 1 H, J=6Hz) 
7.56 (dd, 1 H, J=8.5+ 1.5Hz) 
7.84 (d, 1 H, J=8.5Hz) 
7.98 (d, 1 H, J=1.5Hz) 
6.24 (d, 1H, J=15.5Hz) 
7.08 (dd, 1 H, J=4.8+3.6Hz) 
7.31 (d, 1 H, J=3.6Hz) 
7.43 (d, 1 H, J=4.8Hz) 
7.89 (d, 1 H, J=15.5Hz) 
6.27 (d, 1 H, J=16.0Hz) 
7.33 (d, 1 H, J=5.0Hz) 
7.37 (dd, 1 H, J=5.0+2.9Hz) 
7.56 (d, 1 H, J=2.9Hz) 
7.77 (d, 1 H, J=16.0Hz) 
2.5 (s, 3H) 
6.09 (d, 1H, J=15.5Hz) 
6.74 (dd, 1 H, J=3.6+ 1.0Hz) 
7.10 (d, 1H, J=3.6Hz) 
7.79 (d, 1H, J=15.5Hz) 
Table 3. cont. 
Compound name (abbr.) 
2-methylfluorene-9-ylideneacetic acid 
(2MF9AA) 
3-methylfluorene-9-ylideneacetic acid 
(3MF9AA) 
biphenyl-2-propionic acid 
biphenyl-4-propionic acid 
Compound structure 
OH 
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H NMR: 
2.42 (s, 3H) 
6.73 (s, 1 H) 
8.69 (s, 1 H) 
2.44 (s, 3H) 
6.73 (s, 1 H) 
7.50 (s, 1 H) 
8.85 (d, 1 H, J=7.8Hz) 
7.20-7.64 (m, 5-6H) 
2.44 (s, 3H) 
6.72(s, 1H) 
8.76 (d, 1 H, J=9Hz) 
8.88 (d, 1 H, J=9Hz) 
7.1-7.7 (m, 6H) 
2.46 (t, 2H, J=7.8Hz) 
2.94 (t, 2H, J=7.8Hz) 
7.21-7.44 (m, 9H) 
2.73 (t, 2H, J=7.8Hz) 
3.01 (t, 2H, J=7.8Hz) 
7.25-7.59 (m, 9H) 
A) 
(()0 + 
1-benzothiophene-5-carbaldehyde 
B) 
SMP 
BKG 
89 
60 80 
0 0 
HOAAOH 
malonic acid 
115 
100 120 
0 
ptpendme OH 
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benzothiophene-5-acrylic acid 
204 
187 
159 
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140 160 180 200 
Figure 12. A) Synthesis of benzothiophene-5-acrylic acid (BT5AA). B) Mass spectrum 
of BT5AA. The signal at 204 is the molecular ion. 
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thiophen-2-ylacrylic acid- The synthetic pathway for 2TAA is shown in Figure 13A. 
The product was identified as thiophen-2-ylacrylic acid on the basis of melting point, 
mass spectra, and 1H NMR. M.p. 148-149°C (lit. m.p. 144-146°C, (Zhu et al. 2007)); 
MW calculated for C7H6S02 m/z 154.2; observed 154 (Figure 13B); 1H NMR results are 
listed in Table 3, the carboxyl H was not observed. The 1H NMR spectrum is consistent 
with that reported by Zhu et al. (2007) for this compound which they had prepared by a 
different route. 
thiophen-3-ylacrylic acid- The synthetic pathway for 3TAA is shown in Figure 14A. 
The product was identified as thiophen-3-ylacrylic acid on the basis of melting point, 
mass spectra, and 1H NMR. M.p. 153-154°C (lit. m.p. 149-150°C, (Mamaev 1957)); 
MW calculated for C7H6S02 m/z 154.2; observed 154 (Figure 14B); 1H NMR results are 
listed in Table 3, the carboxyl H was not observed. 
5-methyl-2-thiopheneacrylic acid- The synthetic pathway for 5M2TAA is shown in 
Figure 15A. The product was identified as 5-methyl-2-thiopheneacrylic acid on the basis 
of mass spectra and 1H NMR. M.p. 158-166°C; MW calculated for C8H8S02 m/z 168.2; 
observed 168 (Figure 15B); 1H NMR results are listed in Table 3, the carboxyl H was not 
observed. 
2-methyl.fluorene-9-ylideneacetic acid- The synthetic pathway for 2MF9AA is shown in 
Figure 16A. The product was identified as 2-methylfluorene-9-ylideneacetic acid on the 
basis of mass spectra and 1H NMR. M.p. 199-201 °C; MW calculated for C16H120z mlz 
236.3; observed 236 (Figure 16B); 1H NMR results are listed in Table 3, the carboxyl H 
was not observed. 
3-methyl.fluorene-9-ylideneacetic acid- The synthetic pathway for 3MF9AA is shown in 
Figure 17 A. The intermediate product of 3-methylfluorenone was identified on the basis 
of mass spectra, giving a parent ion of m/z 194 (Figure 17B). The final product was 
identified as 3-methylfluorene-9-ylideneacetic acid on the basis of 1H NMR. Melting 
point was not determined because of the very low yield obtained during the synthesis. 
57 
A) 
cro 
2-thiophenecarboxaldehyde 
B) 
SMP 
BKG 
+ 
65 
60 
0 0 
HO)l_)l_OH 
malonic acid 
109 
97 
80 100 
piperidine 
pyridine 
121 
137 
I 
120 140 
0 
crAOH 
2-thiopheneacrylic acid 
154 
160 
Figure 13. A) Synthesis of thiophen-2-ylacrylic acid (2TAA). B) Mass spectrum of 
2TAA. The signal at 154 is the molecular ion. 
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Figure 14. A) Synthesis of thiophen-3-ylacrylic acid (3TAA). B) Mass spectrum of 
3TAA. The signal at 154 is the molecular ion. 
59 
A) 
_/s~ 
'Lllo 
5-methyl-2-thiophenecarboxaldehyde 
B) 
1EtBx 
SMP 
BKG 
6B 
malonic acid 
97 
BB 1BB 
pyridine 
piperidine _,S~OH 
-u. 
5-methyl-2-thiopheneacrylic acid 
168 
135 151 
123 
12B 14B 16B 
Figure 15. A) Synthesis of 5-methyl-2-thiopheneacrylic acid (5M2TAA). B) Mass 
spectrum of 5M2TAA. The signal at 168 is the molecular ion. 
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Figure 16. A) Synthesis of 2-methylfluorene-9-ylideneacetic acid (2MF9AA). B) Mass 
spectrum of 2MF9AA. The signal at 236 is the molecular ion. 
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Figure 17. A) Synthesis of 3-methylfluorene-9-ylideneacetic acid (3MF9AA). B) Mass 
spectrum of 3-methylfluorenone, the intermediate product. The signal at 194 is the 
molecular ion. 
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The mass spectra of the MW ion calculated for C16H120 2 m/z 236.3; could not be 
obtained because it would not dissolve in a solvent suitable forMS analysis; 1H NMR 
results are listed in Table 3, the carboxyl H was not observed. 
As there was not enough product from the 3MF9AA preparation saved for adequate GC-
MS results, a small portion of the activated derivatized hapten underwent an attempted 
hydrolysis (treatment with NaOH and extracted into chloroform and methanol) to once 
again yield the acid. However, after GC-MS analysis, a molecular ion of 263 appeared 
(Figure 18), while the expected product of 236 did not. It was determined that instead of 
the acid, the dimethylamine of the compound (C18H17NO, m/z 263.3) was generated. 
An effort to hydrolyze the amine product into the carboxylic acid was attempted. This 
involved refluxing the solution in excess NaOH for 24 hours and subsequently extracted 
into chloroform and methanol. After GS-MS analysis, a molecular ion of 263 again 
appeared, and an additional molecular ion of 250 (Figure 19). It was determined that the 
250 ion was the methyl ester of the carboxylic acid (C17H140 2, m/z 250.3), which was due 
to the presence of methanol in the solvent. Despite not identifying the carboxylic acid 
compound by GC-MS, sufficient evidence supports the validation of its synthesis (i.e., 1H 
NMR and GS-MS of derivatives of the desired product). 
biphenyl-2-ylacrylic acid- 2BIPAA, was obtained as a gift from Dr. Harris. It was 
identified as biphenyl-2-ylacrylic acid on the basis of mass spectra. M.p. 200-204 oc; 
MW calculated for C15H120 2 m/z 224.3; observed 224 (Figure 20). The melting point for 
the reduced form of 2BIPAA, 2-biphenylpropionic acid, was 112-114°C (lit. m.p. 122-
1240C (Dice et al. 1950) and 110-113°C (Cook et al. 1950)), and its 1H NMR results are 
listed in Table 3 for the carboxyl H was not observed. 
biphenyl-4-ylacrylic acid- 4BIPAA, was obtained as a gift from Dr. Harris. It was 
identified as biphenyl-4-ylacrylic acid on the basis of melting point and mass spectra. 
M.p. 231-235°C (lit. m.p. 225°C, (Braun and Nelles 1933); MW calculated for C15H120 2 
m/z 224.3; observed 224 (Figure 21). The melting point for the reduced form of 
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Figure 18. Mass spectrum of the dimethylamine of 3MF9AA. The signal at 263 is the 
molecular ion. 
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Figure 19. Mass spectrum ofthe methyl ester of 3MF9AA. The signal at 250 is the 
molecular ion. 
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Figure 20. Mass spectrum of 2BIP AA. The signal at 224 is the molecular ion. 
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Figure 21. Mass spectrum of 4BIPAA. The signal at 224 is the molecular ion. 
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4BIPAA, 4-biphenylpropionic acid, was 154-156°C (lit. m.p. 147-149°C (Kigawa et al. 
1981) ), and its 1 H NMR results are listed in Table 3 and the carboxyl H was not 
observed. 
Hapten to BSA conjugation 
Addition of activated DBT AA to the BSA solutions resulted in visible precipitation in the 
50% DMF/PBS reaction. No conjugate was retrievable from this preparation after 
filtration. The remaining DBTAA-BSA conjugates were quantified and ranged from 3.4 
to 6.3 mg/ml. MALDI-MS analysis revealed DBTAA-BSA conjugation ratios (Table 4) 
were the highest (6.13:1 DBTAA:BSA) for reactions in PBS containing 25% DMF. 
Since the hapten had been added at a ratio of 10:1, but conjugation was 6.13:1, the 
efficiency for this reaction was approximately 60%. The borate buffered solutions 
resulted in ratios ranging from 4.17 to 4.67, while the PBS without added DMF yielded a 
ratio of only 2.96. 
Hapten to OVA conjugation 
Although the haptens (2TAA, 2TPA, 3TAA, 5M2TAA, and 4BIPAA) that were 
employed for conjugation to OVA were added in small aliquots, two different results 
were observed. In some instances, the protein would precipitate immediately upon 
addition of the activated hapten. Otherwise, a precipitate would form in 30 to 60 
minutes. Either consequence resulted in little to no remaining soluble protein as 
determined by a BCA protein determination assay. 
Serum antibody titration 
All serum titrations to the various haptens were comparable to that depicted in Figure 22. 
The immunogen, in this case, 4BIPAA-KLH, was employed and an increase in titer was 
observed following each subsequent immunizations. Titer vales were defined as the units 
of activity in the volume of serum at 50% of the maximum rate. In almost all instances, 
titers were quantifiable after the 3rd and 4th bleed. Using the homologous hapten on 
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Table 4. Conjugation ratios of the DBTAA-BSA conjugates as concluded by MALDI-
MS. 
Observed Changed Molar ratio Conjugate Buffer %DMF Mass Mass (DBT AA : BSA) (Da) (Da) 
0 67,479 1,048 4.44 
Borate 25 67,416 985 4.17 
DBTAA-BSA 50 67,534 1,103 4.67 
0 67,129 698 2.96 
PBS 25 67,878 1,447 6.13 
50 a -- -- --
BSA control PBS na 66,431 -- --
a. Protem lost dunng stenle filtratiOn. 
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Figure 22. A representative serum titration over the course of immunization. Serum was 
from mouseD (1 out of 4) immunized with 4BIPAA-KLH. ELISAs were conducted 
approximately one month after each immunization using plates coated with 4BIP AA-
BSA. The antibody titer for the 4th sera was 500 units/ml (1 unit = 50% max rate = 2 Ill). 
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dissimilar carriers enabled us to exclusively determine the anti-hapten titer (Figure 22, 
Table 5). All mouse titers are presented in Table 5. Antibody titers were approximately 
10 to 100-fold greater for the carrier protein (e.g., KLH) than they were for the hapten of 
interest. 
In one particular case, sera from 2MF9AA-KLH mice, one individual had an extremely 
high titer to the hapten compared to the others in this group. This discrepancy was 
investigated in a later cELISA study. It appeared that mice immunized with BT5AA-
KLH had very little hapten response. In an effort to address if this was because of a 
failed conjugation, BT3AA-KLH sera, which demonstrated titers to the BT3AA hapten, 
were tested using BT5AA-BSA. If any of the cross-reactive specificities were present, a 
titer should be observed in the absence of any reactivity to BSA. Titers comparable to 
those observed against BT3AA-BSA were also observed against BT5AA-BSA (Table 5 
and Figure 23), indicating that the conjugation was successful. The titer to the 
homologous hapten-carrier was 25-fold higher than for the heterologous hapten-carrier. 
The recognition of the free analyte by cross-reactive antibodies was then examined by 
cELISA (below). 
Sera inhibition screenings 
In order to determine the specificity of the serum antibodies, cELISA's were conducted 
exploring various soluble inhibitors (e.g., heterocycles, PAHs ). 
Antibodies raised against 3TAA-KLH are shown to recognize only the 3TAA inhibitor, 
but not the underivatized thiophenes (Figure 24). Similarly, the other single-ring hapten 
antisera to 2TAA-KLH, 2TPA-KLH, and 5M2TAA-KLH sera could not be inhibited by 
any underivatized thiophenes, which included thiophene, methylated thiophenes, 
dibenzothiophene, and methylated dibenzothiophenes. As an additional positive control, 
all of these sera were inhibited by their respective hapten-KLH conjugate (data not 
shown). 
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Table 5. Hapten and carrier protein titers of experimental mice. 
Antibody titer (units/ml) 
Derivatized Homologous Heterologous KLH BSA Thyro 
Hapten Hapten Hapten 
2TAA 5,000-17,000 (n=4} 
2TPA 1 ,000-300,000 (n=4) 
5M2TAA 1 ,000-12,500 120,000-(n=5} 500,000 (n=5) 
3TAA 1 ,000-3,000 (n=4) 
DBTAA 500-25,000 (n=4) 
4BIPAA 500-2,000 13,000-1 00,000 (n=4) (n=4) 
4BIPAA 25,000-33,000 >66,000a 
(BSA) (n=3) (n=3) 
4BIPAA 1,000-11,000 33,000-
(Thyro) (n=4) > 1 oo,oooa (n=4) 
2BIPAA 500-5,000 (n=6) 
BT3AA 2,500-33,000 1 ,000-5,000 50,000-500,000 (n=5} (BT5AA; n=4} (n=4} 
BT5AA nd-50 (n=5) 
3MBT2AA 3,000-25,000 (n=4) 
170-1 ,000* 
2MF9AA (n=5), 100,000-
*one individual 250,000 (n=8) 
= 33,000 
3MF9AA nd-1 ,000 (n=7) 
Carrier protein was KLH in all instances, except where noted in parentheses below the 
derivatized hapten. 
nd = not detectable 
blank boxes indicate assays that were not tested 
a. Titration was not carried out far enough, 50% point exceeds dilution. 
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Figure 23. Titration ELISA of BT3AA-KLH sera against both BT3AA-BSA and 
BT5AA-BSA antigens coated onto microtiter plates. Serum was from mouse F (1 out of 
5) after the 2nd bleed. The titer to the homologous hapten (BT3AA) was approximately 
33,000 units/ml and the titer to the heterologous hapten (BT5AA) was approximately 
1,400 units/mi. 
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Figure 24. Competitive ELISA of 3TAA-KLH sera. The coating antigen was 3TAA-
BSA and the inhibitors were 3-methylthiophene, thiophene and 3TAA (structures 
shown). 
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Conversely, antibodies raised against DBTAA-KLH are shown to recognize all three 
inhibitors tested in this particular assay: dibenzothiophene, 4-methyldibenzothiophene, 
and DBT AA (Figure 25). 
The titers of the individual mice immunized with 2MF9AA varied greatly, in that one 
individual, mouse H (1 out of 5), had a hapten titer of 33,000, while the remaining 4 had 
titers lower than 1,000 despite having received the same immunogen conjugate at the 
same dosing regime. Mouse H serum was not able to recognize 2-methylphenanthrene, 
when employed as an inhibitor in the cELISA, while mouse B, a lower hapten titer 
serum, could, resulting in an IC50 (inflection point; concentration of inhibitor at 50% of 
the response) of 4 J.Lg/1 (Figure 26). 
Sera from both groups of mice immunized with the 4BIPAA-KLH and 2BIPAA-KLH 
were screened in a cELISA for activity towards biphenyl. Sera from mice immunized 
with the 4BIPAA-KLH exhibited high sensitivity to biphenyl with an IC50 value of 0.3 
J.Lg/1, which is approximately 100 times more sensitive than mice immunized with 
2BIP AA (Figure 27). Furthermore, when the other 4BIP AA-carrier immunized mice 
(4BIPAA-BSA and 4BIPAA-Thyro) produced detectable titers, when they were assessed 
for biphenyl specificity, biphenyl could not inhibit, while it could for the 4BIPAA-KLH 
antisera (Figure 28). 
Then, 4BIPAA-KLH sera were also screened against a panel of PAHs (pyrene, 
naphthalene, phenanthrene, biphenyl and anthracene) to provide a profile of which PAHs 
were recognized. This was completed after both the 3rd and 4th bleeds. As shown in 
Figure 29, this sera was specific for the 3-ring PAHs anthracene (1Cso(4th) = 4J.Lgll) and 
phenanthrene (1Cso(4th) = 400 J.Lg/1), as well as, biphenyl (1Cso(4th) = 500 J.Lg/1), but not for 
naphthalene or the larger PAH pyrene. However, one month earlier (i.e., 3rd bleed, 
Figure 30) naphthalene was recognized demonstrating an 1Cso(3rd) of 400 J.Lg/1. Also 
interesting is the minimum amount of change in sensitivity for anthracene (1Cso(3rd) = 6 
J.Lg/1) and phenanthrene (IC50(3rct) = 300 J.Lg/1), while sensitivity to biphenyl (1Cso(3rd) = 20 
J.Lg/1) decreased by 25-fold from 3rd to 4th bleed. 
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Figure 25. Competitive ELISA ofDBTAA-KLH sera (mouse B, 1 out of 4). The coating 
antigen was DBTAA-BSA and the inhibitors were DBTAA, 4-methyldibenzothiophene, 
and d1benzoth10phene (structures shown). 
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Figure 26. Competitive ELISA of 2MF9AA-KLH sera from mice B and H (2 out of 5). 
The coating antigen was 2MF9AA-BSA and the inhibitor was 2-methylphenanthrene 
(structure shown). 
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Figure 28. Competitive ELISA of 4BIP AA sera generated to various protein carriers 
(KLH, BSA and Thyro). The coating antigen for the 4BIPAA-KLH and 4BIPAA-Thyro 
sera was 4BIPAA-BSA, while the coating antigen for 4BIPAA-BSA sera was 4BIPAA-
Thyro. All of these assays employed biphenyl as the inhibitor (structure shown). 
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Figure 29. Competitive ELISA of 4BIPAA-KLH sera (mouse B, 1 out of 4) assessed 
after the 4th bleed. The coating antigen was 4BIPAA-BSA and the inhibitors were 
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Figure 30. Competitive ELISA of 4BIPAA-KLH sera (mouse B, 1 out of 4) assessed 
after the 3rd bleed. The coating antigen was 4BIPAA-BSA and the inhibitors were 
various PAHs: pyrene, naphthalene, phenanthrene, biphenyl and anthracene (structures 
shown) 
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The 2MF9AA-KLH sera was screened against a panel ofPAHs and alkylated PAHs to 
provide a profile of which compounds were recognized (Figure 31 ). The unsubstituted 3-
and 4-ring PAHs exhibit the highest sensitivity with IC50 values ranging from 10 to 60 
)lg/1. The mono-alkylated 3-ring PAH and heterocycle were recognized similarly with 
IC50 values around 30 and 80 )lg/1. The di -alkylated 3- and 4-ring P AHs exhibited good 
inhibition with IC50 values ranging from 80 to 200 )lg/1. The alkylated naphthalenes, both 
di- and tri-substituted, demonstrated less sensitivity (IC50 values > 1,000 )lg/1) than all of 
the other PAHs used in this study. Overall, this sera was specific for 3- and 4-ring PAHs 
and alkylated PAHs, but not for alkylated 2-ring PAHs. 
The titer screening of BT3AA-KLH sera against the heterologous hapten BT5AA 
produced a measurable response. Because the initial cELISA of BT3AA sera conducted 
on plates coated with its homologous hapten, BT3AA, did not demonstrate inhibition 
from benzothiophene, its surrogate target, a heterologous cELISA was performed. In this 
case, the BT3AA sera were first titered against BT5AA to determine its 50% point (refer 
to Figure 23). As a result ofthe cELISA, BT3AA-KLH sera were inhibited by 
benzothiophene when assayed on a plate coated with the heterologous BT5AA hapten 
(Figure 32). 
MAb production 
Numerous (15) fusions were performed on mice immunized with various hapten-carrier 
immunogens. As the goal was to isolate hapten-specific antibodies, fusions resulting in 
linking arm-specific or carrier specific antibodies, were discarded. A few of these were 
also tested for IgG secretion and were positive. The frequencies of these unwanted 
specificities were recorded- approximately 75% were secreting IgG and of those 30% 
were anti-KLH on a single plate. 
Following the fusion of a DBTAA-KLH immunized mouse, 22 positive cultures 
expressed antibody activity towards DBT AA-BSA. From the cELlS A screening of these 
fusion plates, 3 hybridomas demonstrated significant inhibition with dibenzothiophene 
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Figure 31. Competitive ELISA of2MF9AA-KLH sera (mouse F, 1 out of 5) against 
various unsubstituted and alkylated PAHs. The coating antigen was 2MF9AA-BSA and 
the inhibitors were: phenanthrene, anthracene, benzo[a]anthracene, 9,10-
dimethylbenzanthracene, 7, 12-dimethylbenzanthracene, 9,1 0-dimethylanthracene, 3,6-
dimethylphenanthrene, 2,3,5-trimethylnaphthalene, 1 ,4,5-trimethylnaphthalene, 1,3-
dimethylnaphthalene, 4-methyldibenzothiophene and 2-methylphenanthrene (select 
structures shown). 
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and were cloned. The mAb 7B2.3, an IgG2a isotype possessing kappa light chains, was 
selected for use in the biosensor. 
After performing the magnetic bead isolation procedure during a 4BIPAA-KLR fusion, a 
total of approximately 6x105 cells were counted in the hapten-selected fraction. These 
were then plated into six wells of a 96-well tissue culture plate in order to maintain high 
cell density to aid in cell survival and growth. The remaining fraction totaled l.lx108 
cells and was plated into seven 96-well plates. Upon screening, one anti-4BIPAA-BSA 
positive hybridoma was revealed from the supernatant fraction of cells (i.e., not hapten-
selected). Regardless, when screened against biphenyl, no reduction in activity was seen. 
Therefore, this hybridoma was positive for the linking arm and discarded. No hybridoma 
from the hapten-selected fraction revealed any anti-4BIPAA-BSA activity. 
MAb titration 
The titration profile of the purified 7B2.3 was obtained by screening against a coating 
concentration of 1 J.tg/rnl DBTAA-BSA resulted in a 50% point corresponding to 200 J.tg/1 
of mAb (Figure 33). Thiomersal is a common preservative employed at a concentration 
ofO.Ol %. When used at this concentration in a titration ELISA for 7B3.2, there was no 
detectable response. 
MAb inhibition screening 
MAb 7B2.3 demonstrated differential sensitivities for a wide variety of PARs (Figure 
34). The 2-ring PARs biphenyl and naphthalene exhibited virtually no inhibition, the 3-
ring PARs anthracene, phenanthrene, and fluorene exhibit good inhibition with IC50 
values ranging from 2 to 28 /lg/1. The sulfur-containing heterocycle, dibenzothiophene, 
displayed an inhibition (IC50 of 19 11g/l) similar to that of the 3-ring PARs, whereas the 
oxygen-containing PAR dibenzofuran demonstrated a 5-fold less sensitivity (IC50 of 105 
11g/l). The 4-ring PARs chrysene and benzo[a]anthracene were also sensitively detected 
with IC50 values of 0. 7 11gll. The 5-ring PAR benzo[a]pyrene was recognized with the 
highest sensitivity with an IC50 value of 0.5 11gll. Furthermore, another cELISA was 
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86 
0 0 0 
100 0 0 0 
'\1 0 0 D 0 
...:::::--- '\1 ~-...... ~ 0 --o ...._...._ ........ 
-- ---~ ........ 
-===--- ............. 
80 --o...., ~ 
.............. \""-. 
~ ....... '\--' ~ """-. ~ " \ ""-. 0 Q) 
"\" 'o (/) '\1 c: 60 
"\" \ 0 (/) 
"\ ~ \ 0.. ~ 
"\ \\ <( 0 naphthalene (./) "'tz \\ 
::J D biphenyl ~'\ \\ w 40 '\1 dibenzofuran (..) ~ \\ 
-o- fluorene ~ '\ \ 
-o--- dibenzothiophene 
----'\1- phenanthrene ~ \0.. 
-<>-- fluoranthene ~ Q"' 
20 -+--- pyrene \ ""' 
----6- anthracene ~ ........ "-""'- '\1 
............... ,~ 
--A- benzo(a)anthracene ....... ~~ 
-+--- chrysene 
~ benzo(a)pyrene 
0 
0.01 0.1 10 100 1000 
PAH concentration (!lg/1) 
(X) 0 o2 CPO ~ '\ 
--
# 
naphthalene dibenzofuran fluoranthene chrysene benzo[ a ]pyrene 
Figure 34. Competitive ELISA of 7B2.3 against unsubstituted PAHs. The coating 
antigen was DBT AA-BSA and the inhibitors were anthracene, benzo[a]pyrene, 
benzo[a]anthracene, biphenyl, chrysene, dibenzofuran, dibenzothiophene, fluoranthene, 
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conducted employing alkylated P AHs (Figure 35). Here, the alkylated naphthalenes (2-
rings) exhibit more inhibition (IC50 of 60 to 100 Jlgll) than the unsubstituted 2-ring PAHs, 
yet sti1110-fold higher than the alkylated 3- and 4-PAHs (IC50 below 6 Jlgll). While most 
of the 3- and 4-ring alkylated P AHs have comparable IC50 values with the unsubstituted 
PAHs, the mAb is highly sensitive to 2-methylphenanthrene (IC50 < 0.1 Jlg/1). 
The inhibitors selected for a cELISA evaluation are often those compounds within the 
class ofPAHs as they are most likely to cross-react with the antibody. GC-MS analysis 
of the storm water runoff indicated that other unrelated pollutants were present in high 
concentrations. Therefore, to ensure that there was no cross-reactivity with these 
compounds, a cELISA was conducted employing the following analytes: bisphenol-A, 
triclosan, nonylphenol and caffeine (Figure 36). Phenanthrene was assessed as a positive 
control and for reference. Only at extremely high concentrations(> 1,000 J.Lgll) do these 
analytes exhibit any inhibition of the antibody response. 
Biosensor development 
Antibody kinetic analysis 
Kinetic analysis of the 7B2.3 revealed an equilibrium association constant, Ka, of 2.5 x 
108 M-1 with an on-rate (kon) of 1.52 x 105 M-1 s-1 and an off-rate (koff) of 6.10 x 10-4 s-1• 
Equilibrium was also empirically determined to occur within approximately 10 seconds 
on the basis of a series of timed reactions. This demonstrated that the biosensor method 
did not require any additional time for antibody and sample incubation. 
Calibration curves for the biosensor 
The regression curves for the four calibration standards are shown in Figure 37. The 
concentrations of these solutions ranged from 0.3 to 30 J.Lg/1 total PAH. The calibration 
curves have comparable log-linear best fit lines with minimal variability in each line (r2 2: 
0.98). Based on these results, and for simplicity, the phenanthrene standard curve was 
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Figure 35. Competitive ELISA of 7B2.3 against alkylated PAHs. The coating antigen 
was DBTAA-BSA and the inhibitors were 9,10-dimethylbenzanthracene, 7,12-
dimethylbenzanthracene, 9,1 0-dimethylanthracene, 3,6-dimethylphenanthrene, 2,3,5-
trimethylnaphthalene, 1 ,4,5-trimethylnaphthalene, 1 ,3-dimethylnaphthalene, 4-
methyldibenzothiophene and 2-methylphenanthrene (select structures shown). 
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Figure 36. Competitive ELISA of 7B2.3 against other environmental contaminants -
bisphenol-A, triclosan, nonylphenol, and caffeine- found in the stormwater runoff. The 
coating antigen was DBT AA-BSA and phenanthrene was assessed as a positive control 
and for reference. 
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selected for use in field applications; therefore, biosensor assessments were reported as 
phenanthrene equivalents. The detection limit for phenanthrene equivalents, as 
determined by standard EPA method, was 0.3 J..Lg/1 PAHs with a linear range of 0.3 to 30 
J..Lg/1. For field analyses, the detection limit varied from 0.2 to 1 J..Lg/1. The error in the 
method, from triplicate analysis of standard solutions, was usually no more than 10% of 
the signal response (Figure 37). The largest error is seen at the highest biosensor 
response as this is where the P AH concentration is the lowest and is approaching the 
detection limit. 
Solvent effects 
Various amounts of solvent buffer solutions were examined on the KinExA®3000 
(Figure 38). All of the solutions containing DMF and DMSO reduced the signal 
substantially. The 5% solution of methanol and both the acetone-containing solutions 
increased the signal by about 20%, while the 10% solution of methanol increased it by 
almost 50%. A reduced signal was thought to lower the sensitivity of the instrument as it 
would require more antibody molecules to generate a larger signal, which in tum requires 
more analytes to reduce the signal, thereby not improving the detection limit. Therefore, 
methanol and acetone were the desirable solvents, and 5% methanol was the most often 
employed due to its lower evaporative properties. 
Salinity effects 
HMM was diluted to varying concentrations in order to simulate varying levels of salinity 
within the aqueous environment and its effect on the biosensor. Solutions containing 0 to 
38 ppt of salinity did not adversely affect the biosensor signal (Figure 39). Similarly, 
analysis of samples spiked with known amounts of phenanthrene demonstrated no 
discrepancy in response due to the salinity of the sample. Likewise, when assessing 
phenanthrene spiked PBS and filtered YR water samples, no adverse affects were 
evident. 
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Figure 38. Solvent interactions on antibody binding to the antigen-coated beads. All 
values were normalized to the voltage change with no solvent, with the same amount of 
antibody present in each sample, in duplicate. 
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Figure 39. Salinity interactions on the biosensor. Varying salinity solutions of HMM 
were employed. Two phenanthrene spiked HMM solutions at varying salinities were also 
tested and shown above. Dashed lines represent ± 3SD around the mean of the standard 
solution containing no salts. 
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DOC effects 
HA was employed to examine the effects of DOC on biosensor performance. When HA 
concentrations exceeded 800 f.lg/1, the biosensor signal was adversely affected (Figure 
40). The antibody signal dropped approximately 10% from that of the standard solution 
containing no HA. Yet, when HA solutions were spiked with phenanthrene at 2.0 f.lg/1 
and assessed, the response did not deviate greater than 10% around that of the standard 
solution containing no HA. 
Biosensor applications 
Groundwater monitoring 
Samples from wells W7, W5, MW81 and D8 did not require dilution for biosensor 
analysis. The samples from PW01, D3, W6 and MW80 were diluted before analysis. 
The estimated PAH concentrations from the biosensor and GC-MS analyses for each well 
are shown in Figure 41. The GC-MS results are presented as 1) total PAHs (including 
alkylated and unsubstituted PAHs, 2 rings or greater) and as 2) a sum of 6 PAHs 
(phenanthrene, anthracene, fluorene, chrysene, pyrene, and fluoranthrene). Since the 
antibody has greater specificity for the 3- to 5-ring P AHs, it should underestimate total 
PAH if the sample contains a large amount of the lower molecular weight PAHs (e.g., 
naphthalenes). To test this hypothesis, total P AH and 6 P AH were compared to the 
biosensor results. 
Well samples W7, W5, and D8 were below the detection limit of the biosensor and the 
GC-MS analyses confirmed these results- total PAH concentrations were less than 0.02 
f.lg/1. The remaining wells had detectable concentrations of P AHs. Biosensor results for 
wells MW80 and PWOl greatly underestimated total PAH concentrations compared to 
the GC-MS results, but corresponded well with the sum of the selected 6 P AHs. Based 
on GC-MS analysis, both samples contain substantial concentrations of the 2-ring PAHs 
(e.g., naphthalenes). In well samples W6, MW81, and D3, the biosensor overestimated 
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Figure 40. Humic acid interactions on the biosensor. Varying amounts of humic acid 
solutions were employed. Phenanthrene spiked solutions at varying humic acid 
concentrations were also tested. Dashed lines represent ± 3SD around the mean of the 
standard solution containing no humic acid. 
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Figure 41. PAH concentrations (expressed as phenanthrene equivalents, J..Lg/1) measured 
by the biosensor and GC-MS for the wells sampled during the groundwater monitoring at 
the LA Clarke & Son site in Spotsylvania, VA. The white bars are the GC-MS results for 
total P AHs, the hatched bars are the GC-MS sum of the 6 P AHs (phenanthrene, 
anthracene, fluorene, chrysene, pyrene, and fluoranthrene ), and the black bars are the 
biosensor results. There is a good correlation between the biosensor and GC-MS 
methods with respect to GC-MS total PAH (r = 0.58, n = 7) and the 6 PAH sum (r = 
0.79, n = 7). 
97 
the total PAH concentration. Here, the GC-MS analysis detected quantifiable 
concentrations for polycyclic aromatic heterocycles (e.g., dibenzothiophene, methyl-
dibenzothiophene, and benzonaphthofuran) which are not included in the total PAH 
concentration value and cross-react with the antibody. Overall, a better correlation was 
generated when comparing the biosensor results to the 6 PAH sum (r = 0.79, n = 7) than 
to total PAH (r = 0.58, n = 7). Similarly, using Deming regression analysis, the slope of 
the line of best fit for the biosensor results compared to the 6 PAH values was 0.65 ± 0.21 
(se), while to the total PAH values it was 0.11 ± 0.06. 
Estuarine monitoring 
A spatial representation of P AH concentrations measured with the biosensor defines a 
plume ranging from 0.3 to 3.2 11gll (phenanthrene equivalents) with higher PAH 
concentrations closer to the dredge site (Figure 42). Due to the biosensor's rapid and on-
site operation, an area of approximately 90,000 m2 was surveyed around the operating 
dredge site, thus defining the extent of the plume relative to background P AH 
concentrations in the estuary. PAH concentrations at seven of the stations, where 
additional large volume samples were collected, demonstrated a very strong positive 
correlation between biosensor and GC-MS results (r = 0.95, n = 7) (Figure 43). The GC-
MS PAH value is the sum of all detected (LOD > 0.01Jlg/l per analyte) alkylated and 
non-substituted 3- to 5-ring PAHs (11 to 39 compounds identified). As a comparison, the 
16 EPA PAHs (excluding naphthalene) comprised 19 to 41% (with one sample 
containing 88%) of the reported total PAH concentration. The Deming regression slope 
of the line comparing the biosensor to GC-MS total PAH was 0.90 ± 0.14 (se). 
Toxicological study 
The zebrafish toxicological study focused on measuring a single spiked PAH analyte, 
phenanthrene throughout a dosing experiment. Forty-eight samples were collected, 24 
preceding renewal and 24 post renewal to monitor changes in phenanthrene 
concentrations over a span of 5 days. There was a strong correlation between HPLC 
determined PAH concentrations and those determined by biosensor (r = 0.84, n = 48; 
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Figure 42. Near real-time PAH monitoring of the remedial dredging project completed at 
the Money Point site in the Elizabeth River in Norfolk, VA. The PAH concentrations 
determined by the biosensor are represented by the gray circles proportional to 
concentration. (Note, concentrations for the sites labeled beginning with a 'C' are 
reported in Figure 3 as these were validated by GC-MS.) The 'dredge' polygon 
represents the location of the dredging operation. 
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Figure 43. PAH concentrations (J.lg/1) measured by the biosensor and GC-MS (sum of 11 
to 39 analytes) during the estuarine monitoring at the Money Point site along the 
Elizabeth River in Norfolk, VA. There is a strong correlation between the two methods (r 
= 0.95, n = 7). Based on Deming regression analysis, the slope of the line of best fit was 
0.90 ± 0.14 (se). 
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Figure 44 ). Based on Deming regression analysis, the slope of the line of best fit was 1.1 
±0.10. 
Although a strong correlation was observed, the biosensor, on average, overestimated the 
phenanthrene concentration. Since phenanthrene serves as the standard for biosensor 
calibration, overestimation of phenanthrene concentrations suggested that cross-reactive 
phenanthrene oxidation products could be entering the water. The reactivity of 1-
hydroxyphenanthrene (a metabolic by-product detected in the zebrafish tissues) was 
tested on the biosensor and this oxidation product exhibited comparable reactivity to the 
parent compound, phenanthrene (Figure 45). 
Stormwater runoff study 
PAH concentrations measured with the biosensor and cumulative rainfall for the CB and 
YTC sites were documented before, during, and after the rain event (Figure 46, A and B). 
The rain event began at approximately 1 AM local time. At both sites, the initial increase 
of P AH pollutants was measured approximate! y 1 to 2 hours after the rain started. 
Although rainfall ceased at approximately 8 AM, sample collection continued until the 
P AH concentrations declined to background values. From the start of the rain event to 
the end of the intensive sampling session, 17 hours elapsed and 84 samples (14 time 
points, triplicate samples, 2 sites) were collected for biosensor analysis. Typically, two 
of the three replicate samples were analyzed within the hour. In total, the CB site 
received 1 em of rain, while the YTC site received 0.8 em. The peak PAH concentration 
(phenanthrene equivalents) measured was 4.4 J..Lg/1 for the CB site and 3.6 J..Lg/1 for the 
YTC site. Samples were collected periodically during the rain event for GC-MS analysis 
in an attempt to encompass a range of PAH concentrations. The biosensor analyses were 
used to guide this sampling effort due to its generation of near-real-time results. The GC-
MS P AH value is the sum of all alkylated and non-substituted 3- to 5-ring PAHs ( 4 to 9 
compounds identified). Good correlation (r = 0.86, n = 7) between biosensor and GC-
MS results was observed (Figure 47). As a comparison, the sum of the 16 EPA PAHs 
(excluding naphthalene) comprised 50 to 78% of the reported total P AH concentration. 
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The Deming regression slope of the line comparing the biosensor to GC-MS results is 
9.68 ± 2.63. 
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Figure 44. Phenanthrene concentrations (J.tg/1) determined by HPLC and biosensor for 
samples taken during the toxicology study. There is a strong correlation between 
methods in determining phenanthrene concentrations (r = 0.84, n = 48). Based on 
Deming regression analysis, the slope of the line of best fit (shown as a solid line) was 
1.1 ± 0.10. The dashed line is the theoretical 1:1 relationship line. 
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Figure 46. Near real-time monitoring ofPAH concentrations in stormwater runoff during 
a rain event. Concentration profiles of P AHs assessed from samples collected from A) a 
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Creek located alongside U.S. Route 17. Error bars represent the standard deviation of 
three replicate samples. The bars indicate the P AH concentrations and the line shows the 
cumulative rainfall. 
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Figure 47. PAH concentrations (!lg/1) from the stormwater runoff study as determined by 
the biosensor and GC-MS methods (sum of 4 to 9 analytes). There was a strong 
correlation between methods in determining PAH concentrations (r = 0.86, n = 7). Based 
on Deming regression analysis, the slope of the line of best fit was 9.68 ± 2.63 (se). 
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DISCUSSION 
Haptenation efficiency with hydrophobic haptens 
Changes in protein haptenation can influence the activity and specificity of the resulting 
antibody molecule. For example, Klaus and Cross (1974) report that an immunogen 
containing a high hapten:protein molar ratio generally stimulates an lgM response, while 
a low haptenation ratio ( <30) results in high affinity IgG antibodies, perhaps governed by 
antigen-driven selection. Researchers have produced high affinity IgG mAbs using 
immunogens with as many as 26 PAH haptens attached to the BSA carrier molecule 
(Scharnweber et al. 2001, Matschulat et al. 2005, Glushkov et al. 2006); however, they 
were not always concerned with keeping the conjugate soluble. Altering the organic 
solvent concentration could improve conjugation efficiencies while still allowing the 
resulting conjugate to remain soluble despite the increased number of hydrophobic 
haptens. In tum, this would reduce the amount of hapten needed, which is beneficial for 
haptens that can only be obtained in small quantities. Although altering the molar ratio of 
hapten to protein had been previously explored (Malaitsev and Azhipa 1993, Vyjayanthi 
et al. 1995, Singh et al. 2004), to my knowledge altering the amount of organic solvent in 
the reaction mixture had not been investigated. The goal was to produce DBTAA-
conjugates without causing conformational changes that would result in precipitation of 
the conjugate and/or compromising its ability to serve as a screening antigen or 
immunogen. I coupled approximately 6 haptens per molecule of BSA (Table 4) and feel 
that this served us well in terms of effectiveness and ease of use. 
Researchers have historically relied on TNBS and other spectrophotometric methods to 
determine haptenation ratios (Scharnweber et al. 2001, Glushkov et al. 2006). Direct 
measurement by UV /vis spectroscopy is possible when haptens have strong 
chromophores that absorb at longer wavelengths than the protein. TNBS titrations take 
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advantage of the strong trinitrophenyl chromophores of the TNBS to estimate the amino 
groups of the protein remaining free after conjugation with the hapten (Habeeb 1966). 
Some studies comparing MALDI-MS with the spectrophotometric methods have 
concluded that they give comparable results (Singh et al. 2004, Matschulat et al. 2005). 
However, others have observed major discrepancies between these methods (Wengatz et 
al. 1992, Adamczyk et al. 1994). There is evidence that adducts of hydrophobic 
compounds can change the conformation of proteins altering the number of amino groups 
that can be titrated with TNBS. In addition, it may not be possible to completely remove 
unreacted hapten from BSA and other proteins that have hydrophobic pockets. MALDI-
MS avoids these problems. However, there are several limitations with mass 
spectrometric methods: the level of adduction must be sufficiently high and the difference 
in mass of the adducted and unadducted must be sufficiently large that it can be measured 
accurately. Furthermore, the protein must be relatively homogeneous, the conjugates 
need to be soluble and there are mass limitations with the instrumentation. As a 
consequence, BSA adducts are well-suited for estimation by MALDI-MS, but KLH 
adducts are not as their molecular weights are highly variable and high ( -1x106 Da). 
In a comparison of this work with that of Singh et al. (2004 ), where the focus was on 
characterizing protein conjugates based on the amount of hapten added to a solution, this 
method provides a 20% increase in conjugation efficiency. This was achieved in the 25% 
DMF/PBS solution. Both studies added the hapten at a 10:1 molar ratio with BSA and 
made use of MALDI-MS for determining the haptenation ratios. Singh et al. succeeded 
in conjugating an average of 4 molecules, compared to 6 in this study. However, Singh 
et al. only used borate buffer and did not account for the volume of DMF that was being 
added when adding the activated derivatized hapten, although this only amounted to, at 
most, 3% DMF. The borate solutions used in the present study yielded an efficiency of 
40-50%, which is comparable to those published by Singh (2004). This conjugation 
protocol is expected to apply to the other hydrophobic haptens and did apply to other 
common carriers, such as Thyro. This protocol did not prove effective with OVA, but it 
is unclear if this was because too many hydrophobic moieties were being attached to the 
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molecule causing it to precipitate or because the reagents in this method are somehow 
unsuitable for OVA. 
Generation of amines from DMF solvent 
Although it was not intentional to characterize the 3MF9AA hapten after activation, this 
generated a fortuitous result. The goal was to hydrolyze the ester activated product to 
regenerate the carboxylic acid. GC-MS analysis revealed an unexpected amine product. 
This was probably a product of using DMF as the solvent since this activated derivatized 
hapten was used after prolonged storage in the -80°C freezer. As a result, a better solvent 
choice might have been N-methyl-2-pyrrolidone or N,N-dimethylacetamide. Both of 
which are less susceptible hydrolysis in aqueous solutions. Furthermore, DMF instability 
may have had implications in the previous findings referring to haptenation ratios. By 
using DMF solvent, many of the activated haptens may have already been quenched and 
therefore unavailable to react with the free amine groups on the protein, perhaps 
producing a lower haptenation ratio. 
Thiomersal interference 
Thiomersal was completely incompatible with titration ELISA (Figure 33), such that it 
should never be employed as a preservative for prolonged storage with 7B2.3. An 
alternative preservative that has been employed without any adverse effects is sodium 
azide. 
Antisera specificities 
The analysis of serum screenings, both of titers (ELISA) and specificity analysis 
(cELISA), provided new insights into antibody recognition and hapten design. No 
inhibitions were observed with any of the single ring haptens (i.e., 2T AA, 2TPA, 
5MT AA and 3T AA), but inhibition did occur with the 2-ring and larger haptens (i.e., 
BT3AA, 4BIPAA, DBTAA, and 2MF9AA). Although this observation suggests that a 
hapten the size of one benzene ring alone may be too small for an antibody to recognize, 
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trinitrophenyl is a very commonly employed hapten in immunological studies (Rittenberg 
and Pratt 1969). However a key feature of trinitrophenyl is that it possesses three nitro 
groups, which have polar characteristics not present in the hydrophobic P AH and 
aryl thiophene haptens. Increased antibody recognition of polar characteristics is also 
evident in the fact that these same sera could be inhibited by the derivatized hapten 
(Figure 24 ), which possesses an oxygen molecule at the site of attachment to the carrier 
protein. Antibody recognition of the carboxyl group, which is on the distal end of the 
linking arm, suggests that the entire hapten structure, including the linking arm, is being 
recognized within the antibody binding pocket. 
For the individual antiserum that demonstrated a high hapten-carrier titer (i.e., titer values 
>2,000; 4BIPAA-BSA, 4BIPAA-Thyro, BT3AA-KLH, 3MBT2AA-KLH, and 2MF9AA-
KLH (one individual); Table 5), inhibition assays with the underivatized target analyte 
were not successful. Similar observations of high hapten titer with low sensitivity have 
been reported elsewhere employing other small molecules (Danilova 1994, Zhang et al. 
2007). Furthermore, various protein carriers for the 4BIP AA adduct were employed in 
an attempt to generate more hapten specific antibodies. While this seemed to have 
worked- hapten titers were >2,000- similar to the previous findings, neither of these 
sera recognized biphenyl. It is mentioned that the choice of carrier molecule is highly 
important (Fasciglione et al. 1996). However, an immunization scheme such as this, 
employing a variety of carriers with a single hapten, has not often been conducted. 
Varying the coating antigen's carrier molecule has been explored (Marco et al. 1993a), as 
well as, varying the linking arm between the carrier and the hapten (Danilova 1994 ). 
The demonstration of biphenyl inhibition with the 4BIP AA-KLH sera, and not with the 
2BIPAA-KLH sera (Figure 27) is intriguing. The only change in hapten conjugation was 
the position of the linking arm for carrier attachment (Figure 10). For 2BIPAA, the 
attachment at the 2 position on the biphenyl molecule may inhibit free rotation around the 
central bond of the biphenyl moiety (Figure 48). Rotation about the central bond is not 
inhibited with the linker arm attached at C4. This emphasizes the importance of 
preserving identifiable structures of a hapten to allow for desired inhibition or affinity for 
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Figure 48. Spatial illustrations of biphenyl, 4BIPAA, and 2BIPAA. Although biphenyl 
alone appears planar, it can freely rotate around its central bond. This same free central 
bond rotation is preserved in the 4BIPAA where attachment of the linking arm is on the 4 
position. However, as shown in the image of the 2BIP AA, linking arm attachment at the 
2 position reduces the ability of the molecule to rotate as freely. 
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the underivatized target molecule (Marco et al. 1995). While it is common to preserve 
functional groups (e.g., carboxyls, ketones, amines), inherent structural characteristics 
must also be considered when designing a hapten-carrier immunogen. 
Another consideration in hapten design is the length of the linking arm. A length of three 
to six atoms is frequently suggested to be ideal since it is distant enough from the carrier, 
to avoid steric hindrance with the recognition site of the B cell, yet not long enough to 
lead to folding (Marco et al. 1995, Song et al. 2010). Many researchers have been 
successful generating antibodies to P AHs by employing haptens with four carbon spacer 
arms (Meisenecker et al. 1993, Scharnweber et al. 2001, Suchanek et al. 2001). Many of 
the haptens synthesized in this study employed three carbon spacer arms (i.e., acrylic acid 
chains; Figure 10). Two-carbon linking arms were used as three immunizing haptens; 
BT5AA, 2MF9AA and 3MF9AA. Antibodies generated to BT5AA exhibited very low 
hapten titers (<50; Table 5), and the titers for 2MF9AA (excluding one individual) and 
3MF9AA were only a little higher ( <1 ,000, Table 5). As antibody screenings were 
conducted against antigens with the same hapten, but a different carrier, the BT5AA sera 
study suggests that a two-carbon linking arm attached to a two-ring molecule may not be 
sufficient to produce distinct recognition of the hapten. However, the additional ring on 
2MF9AA and 3MF9AA may have led to a portion of the hapten to be distinct from the 
protein carrier. 
A measurable titer could be observed when the BT5AA conjugate (containing a 2-carbon 
linking arm) was employed in a titration ELISA with BT3AA sera. Furthermore, PAH 
inhibition was demonstrated (Figure 32). Heterologous haptens have been employed to 
explore possible heteroclitic responses, wherein the binding of the antibody is greater for 
a hapten other than the one that induced it (Marco et al. 1993b, Abad et al. 1998, Lee et 
al. 1998, Zhang et al. 2007). Conversely, with the homologous hapten employing another 
2-carbon linking arm-containing hapten, 2MF9AA, all but one individual were capable of 
recognizing the P AH (Figure 26 and Figure 31 ). In essence, both heterologous and 
homologous haptens can be employed in cELISAs with haptens containing 2-carbon 
linking arms, even though their success as immunogens was limited. Therefore, although 
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2-carbon linking arms with very small hydrophobic haptens (smaller than 2 benzene 
rings) should not be employed in designing an immunogen, they may still be valuable as 
screening antigens. 
Not only is each individual's antibody repertoire different, these antibody specificity 
profiles can change over time. With each subsequent antigen challenge, or simply by the 
process of affinity maturation, the specificity of the sera changes from recognizing one 
PAH with rather low affinity, to a related one with even higher affinity. This was 
demonstrated by the profiles of 4BIP AA sera over time (Figure 29 and Figure 30). While 
it is crucial to know the specificity of a serum response, it is also impossible to predict 
what profile will be obtained when ultimately generating a mAb, as the serum response is 
a composite of many different antibodies. In fact, not only does the specificity of the 
antibody change, so does the sensitivity. The detection limit was increased by 
approximately 10-fold in 7B2.3 as compared to the antiserum screened for 
dibenzothiophene (Figure 25 and Figure 34). This was expected, given that individual 
antibody-secreting cells are being isolated, fused, and selected based on their sensitivity 
and specificity. Therefore, less effort needs to be focused on screening sera with the 
entire suite of PAHs, and more effort devoted to mAb selection. While polyclonal sera 
could be employed for P AH detection, the changing affinity profile renders them an 
inconsistent option. 
Employing cELISA during mAb development 
The use of a cELISA with the underivatized PAH is essential as antibodies may 
recognize some portion of the hapten-linker-carrier and not strictly the hapten alone 
(Vanderlaan et al. 1988, Danilova 1994). This cELISA should be employed in the initial 
screening of the hybridoma supernatants to confirm adequate activity towards the 
underivatized PAH. A cELISA of the mAb ensures a better likelihood of selecting the 
most specific anti-PAH hybridoma, because fusions tend to yield a low percentage of 
positive cultures overall. 
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A cELISA was carried out by Quelven and colleagues, where they screened the rnAbs 
after the hybridomas had been fully cloned and discovered that only one rnAb had a high 
affinity towards anthracene, whereas the other rnAb only recognized the modified 
anthracene (1999). Even though successful rnAbs have been selected without performing 
a competitive screening (Quelven et al. 1999, Schamweber et al. 2001, Matschulat et al. 
2005), the rnAbs were eventually screened with the underivatized PAH inhibitor. 
Magnetic bead isolation comments 
Although 15 fusions were performed, only one yielded a suitable analyte-specific 
hybridoma. Of those that did not yield a suitable rnAb, the fusion revealed the 
production of IgG antibodies specific for the carrier, indicating that the fusion was a 
success. In an effort to increase the likelihood of fusing a hapten-specific splenocytes 
instead of carrier-specific ones, magnetic beads were employed to concentrate these 
hapten-specific cells. However, because so few were isolated, plating them at a low 
density into only six wells may have reduced their chances of survival. One way to 
overcome the low density is to supplement the well with peritoneal macrophages (Bartal 
and Hirshaut 1987). Another alternative is to conduct subtractive panning, by removing 
the carrier-positive cells and leaving the hapten-specific cells and all of those without any 
surface IgG (Sheedy et al. 2007). Then, a rnicrofluidic device can be employed that 
enables the pairing of these potentially hapten-specific cells to come into direct contact 
with their fusion partner cells while the fusion of membranes is occurring. In tum, this 
could yield a more efficient fusion overall (Skelley et al. 2009). 
Sensitivity and specificity of 7B2.3 compared to other anti PAH antibodies 
Antibody 7B2.3 in a cELISA format can detect dibenzothiophene as well as the other 3-
to 5-ring PAHs in aqueous media at concentrations as low as 0.1 !lgll (0.1 ppb ). Cross-
reactivity analyses performed using select analytes demonstrated that this rnAb 
recognized 3- to 5-ring unsubstituted PAHs, but not those with 2 rings, such as 
naphthalene or biphenyl (Figure 34). Previously, Quelven et al. (1999) developed an 
anti-anthracene rnAb that recognized underivatized anthracene and it also cross-reacted 
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with the same 3- to 5-ring PAHs. An important difference between the Quelven antibody 
and 7B2.3 is that 7B2.3 has more than an order of magnitude higher sensitivity for PAHs. 
The Quelven antibody recognized underivatized anthracene at a concentration of 5 to 10 
J..Lg/1, whereas 7B2.3 did so at 0.1 to 10 J..Lg/1. An anti-benzo[a]pyrene mAb developed by 
Scharnweber et al. could detect benzo[a]pyrene at a concentration as low as 0.3 J..Lg/1 (IC50 
of 8.9 J..Lg/1) and had specificity for mostly 4- to 6-ring compounds (2001). While the 
benzo[a]pyrene mAb seems as sensitive as 7B2.3, 7B2.3 recognizes the 3- to 5-ring 
P AHs, thus increasing its value as a total P AH detector for water samples as the larger 6-
ring PAHs are highly insoluble and 3-ring PAHs are more soluble. Moreover, 7B2.3 has 
been tested with alkylated P AHs demonstrating its ability to quantify more than just the 
unsubstituted P AHs (Figure 35), perhaps providing a better determination of total P AHs 
in a sample. 
Immunoassay performance compared to commercially available technology 
The quantitative trace analysis of select individual PAHs by 7B2.3 was demonstrated in 
an ELISA-based immunoassay format. Thus it has potential as an alternative to HPLC 
and GC-MS techniques for PAH quantification. Overall, the assay takes 2 hours to 
complete and is highly sensitive (down to 0.1 J..Lg/1) for a single analyte solution. For soil, 
there is a commercially available immunoassay test kit, EPA Method 4035 Ensys® PAH 
RIS soil test kit (SDIX), based on using an anti-phenanthrene mAb, which can detect 
PAHs at 1 mg/1 (ppm) (McDonald et al. 1994). Moore and colleagues demonstrated that 
by using the mAb from the soil test kit in a biosensor format (screen-printed electrodes), 
the biosensor possesses a limit of detection of 1.6 ± 0.5 J..Lg/1 (ppb) for PAHs in water 
samples (2004). This assay, and that of Moore et al., are designed to detect water-soluble 
PAHs and are comparable in sensitivity to EPA Method 610 which detects PAHs in 
wastewaters down to 0.2 J..Lgll by means of HPLC. The method described here offers an 
increased likelihood of success, in terms of generating sensitive and selective mAbs, 
compared to previous reported polyclonal and monoclonal antibodies produced by other 
techniques. 
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Biosensor performance compared to the literature 
The primary advantages of this biosensor are its speed, portability and sensitivity, as well 
as the small volumes required and limited sample manipulations. Overall, the biosensor 
provides rapid and precise quantification of P AHs, permitting delineation of small 
changes in concentration. Moreover, the instrument can be transported to the field and 
operated while on-site. This affords higher resolution than previous technology could 
easily allow, and has a myriad of uses in environmental monitoring and management. 
On-site biosensor evaluation of water surrounding a contaminated sediment dredging 
operation documented a spatial distribution of P AH concentrations in near real-time 
(Figure 42). Information about the size and intensity of the plume was provided 
immediately to engineers monitoring the dredging operation from shore and was able to 
verify that the PAH plume never exceeded 10 Jlgll. If the near real-time results had 
shown elevated concentrations were a concern, dredging could have been halted and 
remediative actions put in place. In addition, near real-time data provided information to 
scientists on board the vessel to guide the collection of large volume water samples for 
later analysis of specific PAH compounds. This saved time, effort, and money by 
eliminating the future analysis of samples that might contain PAHs below the detection 
limit of the GC-MS methods. Overall, the data provided by this near real-time assay 
allowed for rapid decision-making about sample collection and remediation effectiveness. 
The biosensor was employed to document a temporal pulse of P AH concentrations at two 
locations during a rainfall event and to time the collection of validation samples. In the 
present study, sample collection for GC-MS validation began 2 hours after the rain had 
started, and continued 4 hours after the rain had stopped (Figure 46), which encompassed 
the period of all elevated PAH concentrations. Since field sites will differ in topography, 
runoff volume, and amount of contamination, the timing of the pulse of contaminants and 
the duration of the elevated fluxes will inevitably vary among sites (Hoffman et al. 1985). 
Moreover, input loads are a function of concentration of an analyte and flow volume over 
time. Since concentrations will vary widely over time, higher temporal resolution of 
measurements can reduce the inaccuracies in estimating input loads of contaminants to 
the system during a rainfall event (Hoffman et al. 1985). As shown in the present study, 
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measurements made after the rain has stopped ( -4 hours later) revealed that elevated 
concentrations were still present (Figure 46). 
By utilizing the biosensor in both of the above applications (estuarine and stormwater 
runoff monitoring), samples indicating a non-detectable PAH concentration (i.e., far from 
the dredge, before the pulse, and at the end of the flux) were not collected for additional, 
more costly laboratory-based analysis. These advantages can result in considerable 
savings of time and money for field P AH determinations. 
The toxicological study permitted analysis of a single analyte (phenanthrene) rather than 
a complex mixture. By analyzing a single compound, superior accuracy was anticipated 
since the analyte was identical to the standard. However, overestimation occurred 
possibly due to the release of oxidized phenanthrene (Sun et al. 2006). These metabolites 
of phenanthrene, such as 1-hydroxyphenanthrene, cross-react with the antibody (Figure 
45), which agrees with other authors' suggestions (Li et al. 2000, Knopp 2006). These 
compounds were identified in fish tissues in the system (Prosser et al. 2011) and may 
have contributed to the biosensor overestimating the phenanthrene concentration in the 
water. 
Validation of the immunoassay method for total P AH quantification in environmental 
samples is difficult as PARs commonly occur as complex mixtures. Conventional 
validation methods (i.e., GC-MS) require the identification and quantification of the 
individual analytes before summation. However, immunoassays bind structurally similar 
groups of compounds resulting in one combined concentration estimate. Therefore, a 
defined number of these individual analytes detected in the conventional method must be 
pre-selected by the analyst to provide a single summed value to which the immunoassay 
method can be compared. To this end, most methods select the 16 EPA priority PAH 
pollutants for quantification. This has resulted in the publication of many studies in 
which immunoassays are reported as overestimating the P AH concentrations found in a 
sample (Barcelo et al. 1998, Knopp et al. 2000, Li et al. 2000, Matschulat et al. 2005) 
with the explanation that this is due to the cross-reactivity of the antibody with similar 
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analytes. Much of the increased antibody reactivity could be cross-reactivity with 
alkylated P AHs, as it is well documented that alkylated species may comprise a large 
fraction of the PAHs in petrogenic samples (Neff et al. 2005, Pies et al. 2008). 
Therefore, the total PAH value determined by conventional methods (as defined as an 
arbitrary set of unsubstituted P AHs) may underestimate total P AH concentration in the 
environment. For this reason, the definition of total P AHs was broadened to include the 
sum of unsubstituted and alkylated homologs when using the GC-MS method. I found 
that the higher the number of analytes detected- 39 analytes in the estuarine study 
compared to 9 in the stormwater study - resulted in a better correlation when comparing 
the total PAH value in the GC-MS and biosensor method (Figure 43 and Figure 47; m = 
0.90 and 9.68, respectively). Similarly, in the groundwater monitoring study, 
heterocycles were present, which were not included in the summation of analytes from 
the GC-MS validation results. This may have contributed to the lower slope for the total 
PAH metric (m = 0.11; 6 PAH, m = 0.65). Nonetheless, immunoassay detection of these 
other compounds may actually be desirable, because it is detecting other structurally 
similar compounds, which exhibit toxicity at comparable or lower concentrations (Neff et 
al. 2005). 
The second confounding issue with validation of an immunoassay method with a 
conventional method is the detection limit of the conventional method. When the target 
analyte is just below the quantitation limit of the conventional method, it will not be 
added to the total. However, the antibody, due to cross-reactivity, will generate an 
additive effect and the resultant value will be the sum of all low level analytes. For 
example, the nearly 10-fold difference seen between the estuarine and stormwater runoff 
studies (m = 0.90 and m = 9.68, respectively) could be a result of the limit of detection for 
individual analytes of 0.011-lg/1 by GC-MS. If the sample were to contain, for example, a 
thousand possible alkylated and unsubstituted P AHs below this limit, a total of 10 llgll 
could potentially be undetected. This is also suggested in the estuarine study (Figure 43) 
where the two highest concentration samples vary considerably in the biosensor response 
but are similar in total PAH concentrations as measured by GC-MS. The highest GC-MS 
value (3.11-lgll) is a sum of 39 analytes with many analytes near the detection limit while 
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the next highest GC-MS value (2.9 )lg/1) is a sum of only 29 analytes and it is likely that 
many additional compounds were just below the reporting limit. Cross-reactivity is 
considered to be a limitation of antibody-based analytical methods, but this feature may 
actually provide a better summation of low level PAHs in complex mixtures not possible 
with targeted analyte-based conventional analyses. A potential resolution, when directly 
comparable results are required, is to calibrate the immunoassay result to the source 
material based on a few confirmatory conventionally assessed samples (e.g., GC-MS) 
(Waters et al. 1997). 
A concern of any conventional on-site field sampling is the need for large sample 
volumes and the preservation and transportation of samples. In these demonstrations, 
sample volumes for biosensor analysis never exceeded 30 ml, although as little as 1 ml 
could be used for biosensor analysis. Sample holding time is another important 
consideration to avoid sample degradation. This can be avoided when employing 
immunoassays as there is little need for sample pretreatment (i.e., extraction or 
concentration) and analysis is conducted on-site promptly after collection. In this study, 
these samples were, at most, filtered or diluted. This also minimizes the amount of 
harmful solvents needed to be taken into the field. The only solvent employed was the 
DMSO used in the biosensor to clean lines between samples; 100 ml of DMSO was more 
than adequate for 50+ measurements. 
Sensitivity, speed, and portability are considered to be the key advantages of 
immunoassays over conventional analytical methods for field monitoring of PAHs. In an 
effort to compare this method with published literature, I found, to the best of my 
knowledge, that no immunoassay has been reported for on-site, quantitative 
measurements of PAHs in aqueous environmental samples. In terms of sensitivity, 
detection limits are often reported in the sub-ppb ()lgll) level without the need for any 
sample pretreatment (Barcelo et al. 1998, Li et al. 2000, Fahnrich et al. 2003, Gobi and 
Miura 2004, Matschulat et al. 2005, Dostalek et al. 2007), which is consistent with these 
results. Of the many immunoassay methods being developed, only ELISA-based 
methods have been employed for the quantification ofPAHs in naturally contaminated 
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water samples (Barcelo et al. 1998, Knopp et al. 2000, Li et al. 2000). This antibody-
based biosensor method required 3 minutes for a quantitative response (including sample 
and antibody mixing time) and an additional 7 minutes for regeneration. Two surface 
plasmon resonance immunoassays report a minimum response time of 15 minutes from 
sample input to data output; one requires an additional few minutes for sensor 
regeneration (Gobi and Miura 2004) and the other requires 30 minutes for antibody 
incubation (Dostalek et al. 2007). A piezoelectric immunosensor for benzo[a]pyrene 
requires 30 minutes for benzo[a]pyrene incubation and then approximately 5 minutes for 
a steady state response (Liu et al. 1999). Although many methods are being developed 
with the promise of quantitative PAH monitoring, none have been exploited for their 
rapid on-site assessment capabilities. (For a review of PAH biosensors, see Appendix A.) 
Field immunoassays can be susceptible to extreme temperature; however, ideal operating 
temperature ranges have only been reported for immunoassays designed for the analysis 
of PARs in soil. The RaPID PAH ELISA (now from SDIX) requires the reagents to be 
within 18 to 27°C (Product Manual). It is speculated by Waters and colleagues that this 
same ELISA could adequately operate in the range of 10 to 30°C (1997). The P AH 
RIS£® (from Ensys) is reported to perform correctly between ambient temperatures of 4 
and 32°C (McDonald et al. 1994). Similarly, with the biosensor, maintaining a 
temperature range of 10 to 35°C ensured proper equipment function and accurate 
analysis. 
Immunoassays have their limitations and optimal operating conditions. Understanding 
what the antibody recognizes determines the value of the assay and how the results 
should be interpreted. I have shown that field-based biosensor analyses can be 
accomplished with good correlation to laboratory-based conventional analytical methods. 
The biosensor provides a rapid generation of results ( 10 to 30 minutes), which guided a 
sampling survey and was used to measure the kinetics of P AH concentrations. The 
biosensor quantified PAH concentrations rapidly in the field using a simple protocol with 
small sample volumes. This technology represents a new tool to allow researchers and 
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environmental managers to document PAH fate in aqueous systems with resolution that 
was previously cost prohibitive. 
Future Perspectives 
While the original goal of developing biosensors was for the rapid detection of 
environmental contaminants, it may be adapted for other applications. Antibody 
platforms could also be used as a preparatory method for isolating and concentrating a 
specific analyte from a sample (Fishman et al. 1998, Perez and Barcelo 2000). Multi-
analyte detection has been briefly explored (Miura et al. 2003, Dostalek et al. 2007) and 
may yield extraordinary uses for biosensors. Namely, biosensors could be employed to 
survey an area with unknown contaminants. Traditional methods require prior 
knowledge about a pollutant in order to determine the proper extraction method. 
Information can be missed if a particular analyte is not retrieved or is lower than the 
detection limit of the method. Once detected on-site by a sensitive biosensor, a larger 
sample can be collected for compound-specific analysis by traditional methods saving 
time and money. Additionally, this current biosensor technology has already been used 
for TNT (Bromage et al. 2007b) and uranium (Melton et al. 2009) analysis. Therefore, it 
is conceivable that they could be combined for multi-analyte analysis. The biosensor 
described here accurately quantifies 3- to 5-ring P AHs, which does not include the 
smaller aromatic PAHs. While the analysis is satisfactory for weathered environmental 
samples, which lack the more volatile 2-ring PAHs (Sauer et al. 1998), it could be 
improved by employing antibodies with specificity for smaller aromatic compounds. 
This would allow accurate total PAH assessments of any aqueous sample. These new 
tools might also be useful to discern contaminate sources and identify their petrogenic or 
pyrogenic origin (Wang and Fingas 2003). Another possible use ofbiosensors is to 
monitor the receiving dose during a toxicological study. Especially important when 
volatilization, sorption, metabolism, etc. of the analyte is of concern and the dose may be 
changing on a time scale not conducive for traditional analysis. 
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APPENDICES 
A. Summary of anti-PAH antibodies presently in the scientific literature 
Antibodies are known to cross-react with molecules of similar structure (Nording and 
Haglund 2003), which presents a great challenge with PAH analysis. Therefore, mAbs 
are selected with the greatest specificity for the P AH of interest. This requires screening 
the mAbs against a broad panel ofPAHs and other molecules (such as PCBs, NPs, etc.). 
Several anti-PAHs antibodies have been developed, varying in degrees of screening rigor, 
and incorporated into immunosensors (Table 6). 
Review of PAH Biosensors (Table 7) 
The most common assay format for the detection of small molecules is a competitive 
inhibition assay wherein a signal-generating antibody is blocked from binding to an 
analyte-coated surface by the presence of free analyte within a sample (Figure 3). The 
antibody and sample are mixed and introduced to the antigen-coated surface. The 
resulting signal is inversely proportional to the amount of analyte in the sample. 
Transducers of this binding event vary and are organized according to type 
(electrochemical, optical, and piezoelectric). For clarification, a table describing the 
various types of transducers and the principles behind the measured values is provided 
(Table 8). 
Electrochemical Detection 
Electrochemical devices measure electrical signals produced from a chemical reaction. 
(Electrochemical cells either produce electrical energy from a chemical reaction, or 
produce a chemical reaction by introducing electrical energy.) When biomolecules are 
involved, the biorecognition event is used to generate the chemical reaction. For 
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Table 6. Summary of antibodies to P AHs 
Antibody Species Type 
BAP-13 mouse monoclonal 
__ 1 
sheep polyclonal 
rabbit polyclonal 
7B2.3 mouse monoclonal 
rabbit polyclonal 
ANT16B4 mouse monoclonal 
405 & 1 OC10 mouse monoclonal 
22F12 mouse monoclonal 
rabbit polyclonal 
anti-BaP-BSA mouse monoclonal 
anti-fluorene rabbit polyclonal 
anti-pyren e rabbit polyclonal 
Conune1ci.1lly available anti-PAH antibodies 
Source Antibody S1)ecies Type 
Nov us BAP-13 mouse monoclonal 
Biologicals 
Abeam 
ExBio 
Abraxis 
Santa Cruz 
Biotechnology 
SO IX 
BAP-13 
BAP-13 
405 & 
10C10 
cr.-Phe n-33 
1. '--'no name designation 
2. np = not provided 
rat 
mouse 
mouse 
mouse 
mouse 
mouse 
rabbit 
polyclonal 
monoclonal 
monoclonal 
np 
monoclonal 
monoclonal 
polyclonal 
3. a total of 14 mAbs were examined in this paper 
Derivatized PAH analyte 
benzo(a)pyrenyl-1-b utyric acid 
benzo (a)pyrene-6-isocyanat e 
dibe nzothio phe ne-4-acrylic acid 
4-(1- pyre nyl)butyric acid 
hemisuccinate of 9-
hydroxymethyla nthracen e 
benzo (a )pyrene-6-isocyanat e · 
y-(7-b enzo[ a] pyre nyl)-b utyric acid 
9,10- Oihy drobenzo[ a]pyre n-7(8H)-
one-7 -(0-carboxymethyl)-oxime 
4-oxo-4-(benzo[ a]pyre ne )butyrate 
flu ore nyl-met hylazide. 
oxy-carb onyl-o-succinimid e 
pyren e derivative 
Reference 
see above 
Refe1ence 
Suchanek et al. 2001 , Scha rnweb er et al. 
2001 
Gift from Ab uknesh a used in 
Goryacheva et al. 2007 
Vo-Oinh et al. 1987 
Spier et al. 2009 
Meisenecker et al. 1993 
Quelven et al. 1999 
Gomes and Santella 1990 
Matschulat et al. 20053 
Roda et al. 1991 
Miura et al. 2003 
Professor F. Le G offic of ENSCP, Paris 
France 
Used in Perez and Barcelo 2000 
Used in Moore et al. 2004, Fahnrich et al. 2003 
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Table 7. Features and specifications of P AH immunosensors 
LOD •range Sl>eed Vol 
Transducer ' Detection TiiiiJet PAH analyte(sl (llgl) (mins) (Ill) Matrix Reference 
Capacitance Linear sweep SaP-BSA na 15 10 buffer Llu et al 1998 
voltammetry 
BaP 25 2-1 ,260 40 np buffer Llu et al 2000 
BaP, acenaphthene, 24 180 5 buffer We1 et al 2009 
CycliC fluorene, fluoranthene, 
Electrochemical voltammetry pyrene, 1-pyrenebutync 
Amperometnc ac1d BaP 2 0, 2 5-2,520 180 5 buffer Wang et al 2011 
Screen pnnted Phen and 16 PAHs 0 8, 0 5-45 90 150 spiked nver, tap, Fahnnch et al 2003 
electrodes sea, and mmeral 
Lmear sweep 
voltammetry phenanthrene 2-100 60 10 Moore et al 2004 
BaP, pyrene, 1 ,260-2,520 30 100 buffer Llu et al 1999, Llu et al 
P1ezoelectnc QCM naphthalene 2000 
SaP 756-2,520 60 500 buffer Bou)day et al 201 0 
macro-flow cell BaP 0 01-300 20 300 buffer M1ura et al 2003, 
and Gobi et al 2003, 
SPR m1cro-flow cell Gobi and M1ura 2004 
Multichannel BaP 0 05-0 18 45 300 buffer Dostalek et al 2007 
F1ber opt1c BaP 0 25 12 5 buffer Vo-Dmh et al 1987 
Pyrene ~2,000 np 10 buffer Yadavalh and Plshko 2004 
Fluorescence Polanzat1on BaP + 16 PAHs 09 np 50 spiked nver Goryacheva et al 2007 Optical water 
3- to 5-nng PAHs 0 3-30 3 400 naturally Sp1er et al 2011 
Intensity contammated 
nver and run-off 
R efl e ctom etn c BaP 3-70 np np buffer Lange et al 2002 
mte rfe re n ce White light 
spectroscopy 
IR mfrared SaP 1 ,260-2,520 60 150 buffer BOUJday et al 201 0, Bou)day et al 2009 
Target analyte = The PAH molecules for which the immunosensor detected in the assay. 
Speed= Defined as the amount of time (estimated to the best extent possible) it takes from sample introduction to electronic result. In 
most cases, protein immobilization is required, but is performed in advance. In the case where the sample requires incubation with 
the antibody reagent, external to the sensor, this time IS included in the speed value. 
Buffer = Solutions vary, such as some contain 10% ethanol. For those details, please refer to the reference provided. 
123 
Table 8. The types of transducers used in P AH biosensors, along with the principle of the 
resulting data. 
Transducer I Detection 
Electrochemical Capacitance 
Amperometric 
Piezoelectric Quartz crystal 
microbalance 
Optical Fluorescence 
Infrared 
Surface plasmon 
resonance 
Reflectometric/ 
interference 
Measurement 
Storage of electric energy (energy storage potential) 
Change in current while applying a fixed potential 
Change in shape producing a measurable frequency 
Change in light intensity 
Change in light intensity 
Change in refraction/reflection of light 
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immunosensors, typically the antigen is immobilized onto the surface of an electrode, 
which ensures that the biorecognition event is occurring near the sensing (or working) 
electrode surface (see review by Grieshaber et al. 2008). However, as the binding of 
antibody to the antigen-coated electrode does not produce a substantial current, the 
antibody is conjugated to an enzyme which is capable of producing the needed chemical 
reaction. These enzyme-labeled antibodies are then introduced to the solution and will 
bind to the antigen-coated electrodes. In a second step, unbound antibodies are removed 
and a substrate is added to the antibody-bound enzymes to generate an electroactive 
product (usually hydrogen peroxide or oxygen), altering the electrical properties of the 
buffer. These electrical properties generate a measurable change in the current 
(amperometric) or the energy storage potential of a solution (capacitance). 
Capacitance 
Electrolytic capacitance measures the ability of the cell to hold an electrical charge. The 
capacitance is dependent on the dielectric properties of the electrodes. For sensors 
employing a biological molecule, the biological molecule serves as an insulating layer, 
such that the distance between the electrodes is influenced by the thickness of the 
biological layer bound on the electrode surface. For biorecognition, either the antibody 
or the antigen is immobilized onto the surface of the electrode. As the corresponding 
antibody binds the immobilized antigen or vice versa, a decrease in capacitance is 
measured proportional to thickness of the dielectric layer, which is due to the amount of 
biological molecule bound. 
A capacitance immunosensor for detecting PAR-conjugates has been described by Liu 
and colleagues (1998). In this assay, the PAH-BSA antigen and the anti-PAH mAb, are 
immobilized onto the surface of gold plated electrodes. For both formats, 10 111 of sample 
solution were transferred to the electrode surface and allowed to incubate for 15 minutes 
before linear sweep voltammetry was employed detecting the cell's capacitance. With 
the antigen immobilized format, specificity for the anti-PAH mAb was demonstrated as 
compared with the nonspecific binding of a mouse lgG molecule. With the mAb 
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immobilized format, antigen samples containing pyrene-BSA and BaP-BSA both bound 
to the mAb while a solution of BSA did not. This was the extent of the investigation. 
Nonetheless, it demonstrated this immunosensor's potential for PAH detection as it could 
employ competitive inhibition where the analyte conjugates could be blocked by PAHs. 
Amperometric transducers 
In amperometric devices, the current associated with the reduction or oxidation of the 
enzymatic product is monitored while applying a fixed potential between the cell's 
electrodes. The current is proportional to the concentration of the electroactive product in 
solution, and therefore to the concentration of antibody binding to the electrodes surface. 
Consequently, the current is inversely proportional to the amount of PAH in solution, 
which inhibits antibody binding to the surface, dampening the current change. 
Importantly, amperometric transducers are less affected by sample turbidity, quenching, 
or interference from absorbing and fluorescing compounds which can confound optical 
biosensors. 
Liu and colleagues (2000) have described an amperometric immunosensor for the 
detection of BaP. A pyrene derivative was immobilized onto a gold plated electrode 
BaP was detected through its competitive inhibition of anti-PAH antibodies binding to 
the pyrene-coated electrode. Presumably, the BaP and antibody solution were allowed to 
incubate with the analyte-modified electrode for 40 minutes, as this was noted as the 
amount of time provided for the antibody solution alone to incubate with the electrode. 
Then, the electrode was immersed in a solution containing the redox probe Fe(CN)63-'4-, 
such that bound antibodies would increase the hydrophobic layer therefore decreasing the 
redox current. Cyclic voltammetry measurements were conducted and the authors report 
quantification ofBaP from 25.2 to 1,260 ~g/1. 
Wei and colleagues (2009) described a similar electrochemical immunosensor for BaP 
employing ruthenium(II)polypyridine derivative as a redox label. Electrodes were coated 
with anti-PAH antibodies. Competitive inhibition was performed by depositing a 5 ~1 
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solution containing a PAH analyte (BaP, acenaphthene, fluorene, fluoranthene, pyrene, 1-
pyrenebutyric acid) and the redox-labeled-PAH onto the electrode and was incubated for 
180 minutes. Cyclic voltammetry measurements were conducted and the LOD for BaP 
was 2.4 ).lg/1 while the other PAHs were examined for cross-reactivity. 
Recently, Wang and colleagues (2011) described another amperometric immunosensor 
for BaP. They increased the number of analyte (derivatized pyrene)-BSA antigens 
immobilized onto the electrode surface by employing dendritic-nanosilica to increase the 
surface area of the working electrode. This subsequently increased the number of 
antibodies taking part in the reaction. The electrode was incubated with a 5 ).ll mixture of 
anti-PAH mAb and BaP for 120 minutes for a competitive inhibition assay. An enzyme-
labeled secondary antibody was then introduced to the electrode and incubated for 60 
minutes, immersed in a hydroquinone solution, followed by exposure to a current. This 
sensor detected BaP with a linear range of 2.5 to 2,520 ).lg/1, and a LOD of 2.0 ).lg/1. 
Guilbault's laboratory (Fahnrich et al. 2003) has explored the use of screen-printed 
electrodes for the electrochemical detection of P AHs. They concluded that the most 
sensitive and fastest assay format was yielded by immersing the phenanthrene-BSA 
coated electrode in a solution of mAb and an enzyme-labeled secondary antibody, with or 
without the PAH sample, and controls for 90 minutes. The. electrode was then rinsed and 
a +300m V potential was applied. After the current reached a flat baseline, a substrate 
was added, which produced a change in the current. This method detected phenanthrene 
from 0.5 to 45 ).lg/1 with a LOD of 0.8 ).lg/1. Specificity analysis was conducted, resulting 
in varying degrees of cross-reactivities with the 16 EPA priority pollutant PAHs, most 
notably, the 3- and 4-ring PAHs. Lastly, spiked water samples (river and tap) were 
evaluated and the system showed slightly decreased sensitivity. 
In a subsequent report, Guibault' s laboratory (Moore et al. 2004) refined this method for 
analysis of a single drop (10 ).ll) of a spiked environmental sample (sea, river, tap and 
mineral water). This method utilizes the displacement of pre-adsorbed mAbs onto the 
antigen-coated electrode surface by the introduction of phenanthrene in the sample. The 
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electrode was immersed with the sample solution for 30 minutes, then washed and 
incubated with an enzyme-labeled secondary antibody for 30 minutes. Following another 
wash step, the substrate was added and linear sweep voltammetry was employed to detect 
the current produced at the working electrode. The linear range of detection for 
phenanthrene was 2 to 100 J..Lg/1. 
Piezoelectric transducers 
Quartz crystals have the unique property of resonating at a given frequency upon 
application of an electric field. A detectable shift in frequency is produced through a 
perturbation to the crystal, such as the adsorption of mass onto its surface, as is the case 
with most antibody-based piezoelectric biosensors. The greater the change in mass, the 
greater the change in frequency. As antibody molecules possess 600 times the mass of 
PAH molecules (i.e., 150 kDa compared to 250 Da), piezoelectric techniques employ an 
antigen-coated platform. PAH detection is conducted via competitive inhibition. 
Without P AHs present in a sample, antibodies can bind unimpeded to the surface, 
decreasing the frequency. However, with increasing PAH concentrations, there was a 
decrease in the frequency modulation by the antibody. 
A piezoelectric immunosensor for PAHs was developed by Liu and colleagues (1999). 
This method employs the immobilization of a BaP-BSA antigen onto a quartz crystal. 
An anti-PAH mAb was then allowed to bind the sensor surface for 30 minutes before the 
introduction of a 100 J..Ll BaP sample. At this step, the flow of the BaP sample was 
stopped for 30 minutes to allow for a competitive displacement immunoreaction to occur. 
The sample was then washed away and the frequency recorded. Because the sensor 
surface is pre-exposed to mAb molecules, an increase in P AH concentration reaching the 
sensor surface causes more antibodies to be displaced with an increase in resonance 
frequency. This technique provided a BaP quantification from 1,260 to 2,500 J..Lg/1. 
Cross-reactivity was demonstrated with pyrene and naphthalene. 
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Boudjay and colleagues (2010) describe another piezoelectric immunosensor for the 
detection of BaP. Instead of immobilizing the analyte-conjugate (a larger molecule), a 
layer of the derivatized analyte (a smaller molecule), pyrene butyric acid, was used to 
coat the surface of the crystals. Antibody and analyte solutions (500 J.tl) were incubated 
for 60 minutes prior to introduction to the sensor surface. The BaP and mAb solutions 
were pumped over the sensor surface at a flow rate of 25 J.tllminute and the frequency 
shift of the antibody adsorption onto the crystal surface was recorded. This method 
resulted in quantification from 756 to 2,520 J.tg/1. 
Optical 
Optically-based transducers possess the broadest range of mechanisms for transduction. 
In the case of PAHs, light can be emitted from the analyte itself or can be generated from 
a fluorescent label affixed to the antibody, the antigen, or the hapten. Light can be 
detected as it is reflected or refracted from the sensor's surface in response to antibody-
p AH binding. 
Surface Plasmon Resonance (SPR) 
SPR-based biosensors operate by detecting a change in the refractive index caused by 
adsorption of a molecule onto the sensor surface. The larger the molecule, the larger the 
change in the refractive index. Since PAHs are much smaller than antibodies (-600 
times smaller), analytes (derivatized PAHs) are covalently attached to the sensor surface 
to capture the larger antibody and effect a substantive change in the refractive index. 
SPR-based PAH immunosensors utilize a competitive inhibition format where the 
concentration of PAHs in the sample is inversely proportional to the change in refractive 
index (Figure 4 ). If there are no PAHs in the sample, all of the antibodies will bind to the 
sensor surface generating a greater shift response. Two SPR-based immunosensors have 
been described for the detection of BaP. 
Gobi and Miura (Gobi et al. 2003, Miura et al. 2003, Gobi and Miura 2004) have 
described both a macro- and a micro-flow cell, SPR-based immunosensors for the 
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detection of BaP. Both methods used the same anti-BaP mAb developed against a BaP-
BSA immunogen. This same immunogen, BaP-BSA, was also used as the antigen in all 
of their studies. These methods require an antibody and sample incubation step for 5 
minutes and then incident angle reached a plateau in approximately 15 minutes resulting 
in a total time of 20 minutes for sample analysis. They reported a BaP quantification 
range of 0.01 to 300 J..Lg/1 and no-cross reactivity with a second analyte, HBP. This is the 
largest range of quantification (105) reported for any PAH immunosensor to date, 
however results were as much as+/- 2 times the actual BaP concentration. The micro-
flow-cell method requires 300 J..Ll volume of a sample. 
A second SPR-based method was described by Dostalek and colleagues (2007). Their 
immunosensor used a 30 minute analyte and antibody incubation step. The sample and 
antibody mixture was permitted to flow over the sensing channel for 10 minutes, 
followed by a wash step for 5 to 7 minutes. In all, it took 45 minutes from the incubation 
of the sample with the antibody to obtaining a signal response. The LOD for BaP was 
0.05 J..Lg/1 with quantification up to 0.18 J..Lg/1. Selectivity of this method was examined in 
two ways; by testing the cross-reactivity of the antibodies (anti-ATR, anti-2,4-D, anti-4-
NP, and anti-BaP) for recognition of the coated antigens (ATR-BSA, 2,4-D-BSA, BaP-
BSA and 4-NP-OV A) and by incubating the anti-BaP antibody with a mixture of four 
analytes (BaP, ATR, 2,4-D, and 4-NP) at one specified concentration in buffer. Although 
the anti-BaP antibody significantly cross-reacted with the 4-NP-OV A antigen (64% ), the 
anti-BaP antibody reportedly demonstrated no discrepancy when incubated with the BaP 
analyte alone or in the mixture. 
Fluorescence-based detection 
Fluorescence detection is considered a more sensitive technique than other 
spectrophotometric methods. Fluorescence is produced when sufficient energy is 
absorbed to excite a valence electron from its ground state to an excited state and a 
photon is emitted after its relaxation to the ground state. In the immunosensors that 
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follow, this fluorescence is produced from either the excitation of the P AH molecule 
itself or by a fluorescent tag conjugated to one of the reagents. 
Natural PAH fluorescence. The first anti-PAH method employing fluorescence detection 
was conducted by Vo-Dihn (1987). The fluorescence was emitted by the BaP molecule 
upon exposure to a laser, an inherent property of BaP. Rabbit anti-BaP polyclonal 
antibodies were covalently attached to the tip of a fiber optic cable. This served as the 
probe, which was placed in a sample solution and incubated for 10 minutes. The probe 
was then rinsed with PBS and exposed to a helium cadmium laser in order to elicit 
fluorescence. In all, sample analysis was reportedly completed in approximately 12 
minutes. The signal was proportional to the number of BaP molecules bound to the tip of 
the probe. The sample size needed was 5 f.ll, and in this volume 1 fmol could be detected, 
which is equivalent to 0.25 f.lg/1. However, this technology suffers from high non-
specific binding of P AH to the cable itself. 
Polarized fluorescence. Yadavalli and Pishko (2004) employed an anti-PAH mAb 
labeled with a fluorophore. A solution containing analyte and antibody was passed 
through a microfluidic channel where it was exposed to polarized excitation light. The 
antibody bound to the analyte resulted in a larger, slower rotating entity that was reflected 
by the increase in fluorescent anisotropy. It is worth noting that fluorescence polarization 
is the only PAH immunosensor method, described to date, that does not use any form of 
immobilized antigen nor antibody. The authors noted that typical assays were conducted 
on <10 f.ll samples, however it was unclear how much was used in their experiments. 
They noted a LOD of 10 to 40 nM, which, if this was detected in a 10 f.ll sample, would 
result in a LOD of approximately 2,000 f.lg/1. The authors analyzed other aromatics 
(benzene, toluene, and anthracene), but could not conclusively report their detection. No 
mention of antibody incubation time or speed of analysis was provided. 
Goryacheva and colleagues (2007) employed fluorescence polarization, where contrary to 
the previous study, they fluorescently labeled an analyte tracer and not the antibody. 
Similar to the previous study, there was no need to separate the bound and unbound 
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antibodies, because as the fluorescently-labeled tracer is bound, there would be an 
increase in fluorescence polarization. In this investigation, the method was based on 
competitive inhibition with PAHs in the sample competing with the labeled tracers for 
antibody binding. Two anti-PAH antibodies, a mAb and sheep polyclonal, were 
employed. Different PAH tracers were explored (2, 4, and 5 rings), as well as 
characterization of cross-reactivity of the mAb/antisera with 16 PAHs. The polyclonal 
antibodies detected all analytes, while the mAb preferentially bound the 4- to 5-ring 
PAHs. No incubation time was required, as both mAb and polyclonal antibodies came to 
equilibrium immediately upon mixing the reagents, but total analysis time was not 
provided. No matrix effects were evident when environmental river samples were spiked 
with known amounts of BaP. 
Fluorescence intensity from a label. Spier and colleagues (2011) report a completely 
automated PAH immunosensor based on detecting the intensity of a fluorescently-labeled 
mAb. Antibody characterization demonstrated that the mAb recognized 3- to 5-ring 
PAHs (Spier et al. 2009). Analyte-protein conjugates were immobilized on PMMA 
beads loaded into a flow cell positioned in front of a laser. As the mAb came to 
equilibrium quickly, no additional incubation with the sample was required. A 400 J.Ll 
solution of sample and antibody were passed over the bead-packed flow-cell, where the 
fluorescently-labeled antibodies would either bind to the antigen-coated beads, or were 
inhibited from binding by P AHs in solution. For a sample containing no P AHs, the 
tagged mAbs provide the greatest fluorescence intensity. Thus, the fluorescent signal 
was inversely proportional to the concentration of PAH. The linear range of PAH 
quantification was 0.2 to 30 J.Lg/1. Samples were analyzed in 3 minutes, with an 
additional 7 minutes for cleaning and preparing the sensor for the next sample. This 
study evaluated natural water samples contaminated with a complex mixture of P AHs. 
Validation analysis with GC-MS demonstrated good correlation and accurate 
quantification of 3- to 5-ring P AHs. 
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Retlectometric interference UV /VIS spectroscopy 
One of the first automated immunosensors for BaP detection was described by Lange et 
a1 (2002). The aim of their study was characterization of anti-BaP polyclonal antibodies 
rather than to produce a rapid, portable instrument. They demonstrated that the 
polyclonal antibodies (Vo-Dinh et al. 1987) were specific for BaP and not for chrysene 
and pyrene. This method employed a flow-injection system, a analyte-coated transducer 
surface, and a UV NIS spectrometer. The principle of this method was that as antibodies 
bound to the analyte-coated transducer surface, the reflectance pattern of the continuous 
white light aimed at the transducer surface changed and was measured with good 
resolution. The antibody reaction was based on competitive inhibition where the 
maximum signal was produced when no BaP present and all of the antibodies can bind 
the sensor coated surface. Increasing BaP concentrations caused less antibodies to bind 
to the surface and therefore less reflected white light was observed. This method had a 
working range of 3 to 70 )lgll of BaP. As speed was not a concern of this study, pre-
incubation of antibody with sample was conducted, but no times were provided, however 
a signal response was generated in less than 250 seconds. 
Infrared 
Boudjay and colleagues employed IR absorption technology for the development of a 
BaP immunosensor (2009). An IR signal was produced when the antibody binds a BaP 
molecule - a new IR band formed, indicative of the presence and stretching of the 
aromatic C-H band of BaP upon interaction with the antibody. Therefore, the 
concentration of BaP in a sample is directly proportional to the integrated area of this 
band. This method relied on the direct immobilization of the mAb onto the sensor 
surface and required no additional labels. A 10 m1 solution ofBaP was exposed to the 
antibody-coated surface for 60 minutes, washed and then the IR spectrum recorded. This 
label-free, direct IR method demonstrated a LOD for BaP of 1,260 )lg/1 with a measuring 
range up to 2,520 )lg/1. In a subsequent publication, Boudjay and colleagues (2010) 
reported the employment of this IR method in an indirect competitive format, where the 
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BaP-surrogate antigen was coated onto the immobilized surface, yielding the same BaP 
LOD of 1,260 J.!gll. 
Current state of PAH biosensor technology 
The majority of P AH immunosensors possess detection limits in the J.Lgll range (Table 7) 
making them suitable for measuring environmentally relevant concentrations. Rapid 
analysis is a desirable trait for biosensors and most of these can complete P AH analysis 
in minutes. For sensors requiring more than 30 minutes, sample incubation was required 
to allow the antibody to come to equilibrium with any available analytes. While 
sensitivity and speed are desirable traits for biosensor methodologies, biosensors must 
transcend the controlled situation of the laboratory to make field assessments routine and 
reliable. Namely, matrix effects must be evaluated with complex environmental samples 
and PAH mixtures, as well as validation of results with traditional analytical methods. 
Portability, automation, and user-friendliness are issues of paramount importance. 
Comparisons of biosensor and classical analytical methods 
The main goal for developing PAH immunosensors is to perform rapid, on-site PAH 
analysis. This is to replace or assist traditional methods, which require samples to be 
analyzed by laboratory-bound techniques such as GC-MS or HPLC. To accomplish this, 
biosensor methods must employ samples that can be assessed in the field without 
extensive manipulations, such as extraction or concentration. The biosensor methods 
require small volumes, ranging from 5 to 500 J.!l per sample. In comparison, for low-
level detection, classical analytical methods require up to 1 L per sample. Because the 
sample volume is large in classical methods, the analytes of interest must first be 
extracted into an organic solvent and then concentrated. For analysis of a single sample, 
the analytes are then separated and individually identified. Depending on the number of 
identifiable analytes, this process can take hours to days to complete. Although biosensor 
methods do not provide resolution of individual analytes, sample analysis can be 
completed in minutes. In return, a much greater number of samples can be assessed with 
less time, effort, and expense. 
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As reported in this review, most of these biosensors have only been tested with single 
analyte samples. However, PAHs in the environment commonly exist as complex 
mixtures. Moreover, these compounds possess similar molecular structures and electron 
density. As demonstrated in several anti-PAH antibody characterization studies, these 
antibodies are highly cross-reactive with other PAHs (Nording and Haglund 2003). 
Therefore, if the final goal is to employ the biosensor for precise analyte identification 
during environmental analysis, samples containing relevant complex mixtures of PAHs 
must be resolved and confirmed with traditional analytical methods (Rodriguez-Mozaz et 
al. 2006). 
Antibody incubation times 
The analysis time for the biosensors presented here is reported as the amount of time 
required from the moment the sample is introduced to the system. This includes 
incubating the sample with the antibody, typically conducted for 30 to 60 minutes. 
However, most of the methods described do not utilize antibodies for which kinetic 
analyses have been completed. If an antibody comes to equilibrium with a sample in a 
very short amount of time, this incubation step can be reduced or eliminated. This is the 
case for the antibodies employed in the Goryacheva et al. (2007) and Spier et al. (2011) 
studies. If kinetic analysis were to be conducted for the other antibodies employed, 
analysis times may be shortened in the future. 
Comparison of label-free and labeled reagents 
Both, label-free (Figure 49) and labeled methods have their advantages. With less 
reagents, less steps can be involved. When labels are employed, they require covalent 
attachment to the antibody or antigen. This conjugation process can place labels within 
the antibody binding site, thereby decreasing the antibody's potential activity. The 
natural fluorescence of PAH molecules allow label-free detection; however, protein 
molecules and other natural organic substances may fluoresce at a similar wavelength. 
Fluorescent labels can provide a narrow targeted wavelength and optical filters can be 
incorporated to increase the specificity of the signal. 
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Figure 49. Label-free detection methods. A) infrared spectroscopy or natural 
fluorescence emitted from a PAH molecule, B) electrical storage (capacitance), surface 
plasmon resonance, or light reflectance/interference C) piezoelectric. 
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Reusability of biosensors 
Reversible binding of antibody-antigen systems (i.e. sensor reusability) can be exploited 
to increase the useable life of some biosensors. To regenerate surfaces (removing 
previously reacted antibodies or antigens) a variety of chaotropic and proteolytic reagents 
have been used, including; urea (Liu et al. 1999), MgCh (Liu et al. 2000), pepsin (Gobi et 
al. 2003, Miura et al. 2003), and NaOH with acetonitrile (Dostalek et al. 2007). An 
immunosensor has been reused successfully as many as 50 times, while others have 
experienced high retention of the previous reactants. This is very likely a function of the 
antibody's affinity or non-specific binding with the sensor surface. Likewise, the choice 
of chaotropic reagent will vary depending on the types of materials incorporated into the 
lines and seals of the sensor instrument. While this is certainly an avenue that can be 
explored, it is unclear if it is critical for successful field deployment. Regeneration would 
involve more reagents, but may also eliminate the need for numerous sensing surfaces 
and could reduce the reagents required in preparatory stages (i.e., antigen or antibody 
coating). 
Applications to other areas of health and disease 
PAH detection is not only occurring in aquatic environmental samples, but also has been 
completed extensively in food sources (EU 2002) by GC-MS methods. Human exposure 
to P AHs is also conducted via examining urine samples for P AH metabolites 
(Jongeneelen et al. 1985), and antibody-based assays have already been developed for 
one PAH metabolite (Marco et al. 1993a). Similarly, human exposure to PARs typically 
results in the formation of PAH-DNA adducts, which can serve as another biochemical 
molecule to detect via PAH biosensor (Vo-Dinh et al. 1987). Likewise, the methods 
presented in this review are only specific for PARs due to the incorporated antibodies. 
By changing to other antibodies, these biosensors could be adapted to quantify any 
molecule for which an antibody can be developed. 
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Simultaneous Syunge Wash 
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